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Abstract
Techniques that enable the creation of instructive biomaterials have the potential to advance our under-
standing and ability to guide cell fate and function. Benzophenone (BP) photolithography is uniquely
suited to generating chemically and mechanically tailored materials because of its molecularly general and
spatially modulated characteristics. Here, we describe the application of this methodology to investigate
two important biological processes in the context of mechanical and biochemical cues. First, we generated
gradients of cellular adhesion molecules that allowed us to understand the mechanism by which bromelain
affects cell rolling during the early steps of inflammation. The latter part of this work utilized BP-mediated
immobilization on two substrates, collagen-glycosaminoglycan membranes and polyacrylamide hydrogels, to
evaluate stem cell differentiation. In summary, we have developed a photoreactive platform that provides
the capability to control biomolecule density separately from mechanical properties. This strategy can be
used on a variety of biorelevant substrates to replicate the properties of the native extracellular matrix.
Our results shed light on the combinatorial influence of multiple cues and have the potential to identify key
parameters to specifically alter cell response with a view towards tissue regeneration.
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Chapter 1
Introduction and Background
1.1 The extracellular matrix: a complex and dynamic
environment
The extracellular matrix (ECM) is a hydrated network of proteins surrounding cells that provides biomolecu-
lar, mechanical, and spatial cues. It consists mainly of fibrillar structural proteins (e.g. collagen) mixed with
glycosaminoglycan sugars and additional adhesive proteins (e.g. fibronectin). The ECM is synthesized and
remodeled to some extent in healthy tissue through the action of matrix metalloproteinases (MMPs), but
dysregulation is associated with tumor metastasis, cardiovascular disease, and other pathological states.1,2
Matrices play an important role in tissue development and function by controlling cell growth, migration,
and differentiation. In addition to providing physical support, the ECM mediates cytokine signaling via se-
questration of soluble growth factors. Furthermore, the cues described are not simply “on” or “off,” but have
precise spatiotemporal patterns critical to proper tissue development and function analogous to embryonic
development.
Cells in the human body constantly encounter an array of stimuli that influence their behavior and
tissue-specific processes. The interaction of cells with adhesive surfaces is especially complex due to its
reciprocal nature.3 Underlying substrate stiffness affects cell adhesion, spreading, and differentiation.4,5
Cells adhere to their surroundings through specific integrin receptors, which recruit focal adhesion complexes
that bind the actin cytoskeleton to the ECM. Moreover, growth factors have been shown to modulate
the activity of integrins in the cell membrane; for example, platelet-derived growth factor (PDGF)-BB
stimulates integrin synthesis,6 and modulates integrin mobilization and focal adhesion dissociation.7 In
turn, integrins can repress growth factor receptor availability through internalization (e.g. integrin-mediated
bone morphogenetic protein receptor endocytosis8). Recent studies indicate that control of cell spreading,
through manipulation of substrate stiffness or adhesion geometry or area, strongly influences cell growth
and differentiation.9,10 Unraveling the influence of physical factors and growth factors, which are known to
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activate the same signaling pathways inside the cell, is a key challenge in understanding and regulating cell
fate.
Regenerative medicine, through controlling and directing the healing process, has tremendous potential
in the clinical setting. The body has the capacity to respond to tissue injury through inflammation and
subsequent repair. Both the inflammatory and regenerative processes are tightly regulated through release
and recruitment of growth factors coordinated by the ECM. A better understanding of cellular response in
tissue inflammation and repair, leading to more effective strategies to harness this knowledge for therapeutic
applications, is the motivation behind this dissertation. Improved methods for generating instructive mate-
rials will be critical for studying the molecular basis of cellular behavior. The ability to create biochemically
defined material surfaces is an important tool for advancing this research.
1.2 Surface modification techniques to create custom cell
microenvironments
A key challenge in current biomaterials research is to quantitatively determine cell response to individual
and multi-parameter inputs. Early in vitro studies relied on supplementation with freely soluble factors to
explore cell response; however, this approach is limited by diffusion away from the desired area and does
not recapitulate the native immobilization of bioactive molecules to the ECM. Furthermore, immobilized
biomolecules have been shown to have enhanced bioactivity compared to controlled release of soluble fac-
tors.11 Importantly, immobilized biomolecules have the potential to be spatially patterned in a manner
characteristic of the microenvironment in which cells live. A myriad of techniques have been developed
to achieve localized biomolecule presentation. Physical adsorption is the simplest approach, but may not
be stable over time. Self-assembled monolayers (SAMs) of alkanethiols present an attractive strategy for
controlling surface modification.12 Spatial patterning can be achieved by directly depositing biomolecules
using an AFM tip (dip-pen nanolithography, DPN). DPN allows for extremely high-resolution patterns, but
it is slow and not multiplexable, so its usefulness is limited to applications requiring nanoscale features.13
Additionally, SAMs are limited to gold or silver surfaces. Patterns may also be created using microcontact-
based printing, the use of which has since been expanded beyond SAMs to substrates such as polystyrene.14
Another direct-write patterning method, inkjet printing, allows immobilization without surface contact and
can be applied to more biologically relevant surfaces.15 Yet none of these techniques offer the capability to
generate discrete, immobilized, bioactive patterns and gradients of different classes of biomolecules without
elaborate experimental configurations.
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Photolithography is a powerful approach that combines excellent throughput, the flexibility to create
features of arbitrary shape and size, and high resolution (below the scale of single cells). To create patterns,
a photoreactive compound is exposed to light in a spatially defined manner resulting in covalent attachment of
the ligand of interest. Other lithography techniques, such as electron beam or ion beam lithography, require
exposure to extreme environments (e.g. high vacuum)16 and so cannot be used for bioactive molecules
without affinity-based schemes that require exogenous functionalization of the molecules to be patterned.17
Like other affinity-based conjugation techniques, the number of species that can be bound is limited. In
contrast, photolithography can be carried out without the need for functionalizing the molecule of interest.
All of the work described in this dissertation relies on photolithography to generate instructive materials.
1.3 Surface patterning and benzophenone: using light as a
reagent to enable instructive biomaterials
A number of ligands useful for generating covalent bonds in response to light have been explored in pho-
toaffinity labeling literature. Among the available classes of molecules that could be incorporated into
biomaterials, benzophenone (BP) compounds have a number of distinct advantages. Benzophenone under-
goes an n→ pi* transition upon excitation with UV light, forming a triplet diradical state. The excited
species then abstracts a hydrogen from a nearby C-H bond and recombines, which is the most favorable
conjugation. Alternatively, an electron transfer followed by proton abstraction and radical recombination
may occur (e.g. from amines).18 Ideally, the photoreactive moiety should not require any specific functional
group but instead have rather broad reactivity; hence, the preferential reaction of benzophenone with C-H
bonds is valuable for attaching a variety of biomolecules. The absorption of UV light around 360 nm is
advantageous, since shorter, more energetic wavelengths could damage sensitive biomolecules, while higher
wavelengths would cause instability in ambient light. An important advantage of photolithography is the
ability to create overlapping patterns by serial exposure of the substrate using different photomasks. The
ability of benzophenone to relax to the ground state and be re-excited is essential to this application. In con-
trast, many other photoprobes undergo irreversible excitation. Furthermore, benzophenone is more stable
than diazo esters, aryl azides, and diazirines.18 Overall, benzophenone-mediated photocovalent attachment
is optimal as a molecularly general technique for immobilization on bioactive surfaces.
Photolithography using benzophenone has been shown to be a useful surface patterning methodology for
immobilizing lipids, proteins, and antibodies,19 among other components;20–22 however, authors have not
utilized the generated patterns for biological applications. BP-mediated biomolecular patterns generated
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in our lab have validated control over surface density23 while maintaining the bioactivity of patterned
molecules: direct immobilization of overlapping patterns or opposing gradients of protein and carbohydrate
moieties, and recognition of immobilized P-selectin by its ligand P-selectin glycoprotein ligand-1 (PSGL-1)
in solution and via engagement with HL-60 cells through cell-surface-expressed PSGL-1.24 The basic scheme
for producing patterns is to functionalize the substrate surface with benzophenone, incubate the substrate
in an aqueous solution of the molecule of interest, and expose the specimen to 365 nm laser light though a
photomask. Unlike methods that involve copolymerization of biomolecules within the matrices themselves,
photolithography allows spatial modulation of immobilization. This process has the advantage of separating
material fabrication from both biomolecule patterning and subsequent cell incorporation.
Most studies that focus on cell-material interactions have been centered around manipulation of a single
factor, which presents only a small fraction of the total interactions that take place in the microenvironment.
Given that biochemical cues act in concert with physical stimuli to directly affect cells, the respective
contributions and interactions of these cues is difficult to distinguish. Due to the complexity of forces cells
experience, multi-parameter control of material characteristics will be necessary to elucidate the interplay
of these factors. This added level of control over substrate stiffness, combined with the benzophenone
methodology for creating overlapping biomolecular patterns, allows systematic investigation of cell behavior.
Development of such modular biocompatible materials is crucial to recapitulate the complex ECM and enable
new insights in tissue regeneration.
1.4 Untangling the cellular microenvironment: overview of work
presented herein
This thesis presents an overview of the important role of the extracellular matrix, strategies for mimicking
its properties, and finally the development and application of benzophenone photolithography to illuminate
the biology of inflammation and stem cell fate through instructive materials.
Chapter 2 describes the application of BP photolithography to investigate the anti-inflammatory mecha-
nism of the proteinase bromelain using in vitro cell rolling assays on two-dimensional glass substrates. This
study builds on previous work reported by our group, showing that multi-component surface-immobilized
gradients can be used to understand the dynamic transition from leukocyte rolling to leukocyte adhesion
during the early stages of the inflammation process.25 The results reported in this chapter establish how
bromelain influences leukocyte rolling by specific cleavage of PSGL-1 on the cell surface and subsequent
reduction in P-selectin binding activity.
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It has increasingly become clear that substrates are not simply inert surfaces, but regulators of cell
behavior through microstructure and mechanical properties. Therefore, the majority of the work discussed
in this dissertation focuses on moving away from planar, non-compliant materials and towards mechanically
and chemically tailored materials. Chapter 3 focuses on the interplay of growth factors and substrate
stiffness on collagen-glycosaminoglycan scaffolds. Collagen is the most plentiful protein in the human body,26
and as the major structural ECM component it supports cell adhesion and growth. Despite the wide
use of collagen scaffolds in tissue engineering, there existed no suitable method for generating spatially
controlled multi-component biomolecular patterns in collagen scaffolds. Additionally, owing to their porosity,
collagen-glycosaminoglycan materials are not amenable to many of the direct surface patterning methods
described above. Preliminary findings from our lab established this technique as a viable method for attaching
proteins while maintaining cell viability.27 Here we report the application of BP photolithography on collagen
membranes to reveal combined effects of proliferative factors, osteogenic factors and substrate stiffness on
mesenchymal stem cell fate decisions. Results suggest that a complex interplay of these factors is responsible
for controlling cell activity.
Despite their success, natural materials such as collagen have some disadvantages as biomaterials. Colla-
gen presents native cues that cannot be overlooked, and its bulk mechanical stiffness is orders of magnitude
higher than native tissue. In chapter 4, we chose to apply the BP methodology to synthetic bioinert hy-
drogels. Polyacrylamide hydrogels provide a blank slate with which to investigate cell behavior and are
mechanically tunable to achieve a closer approximation of the elastic modulus of tissues. Taken together,
the studies in chapters 2, 3, and 4 show the utility of benzophenone photolithography to elucidate cell-
material interactions and accelerate fundamental biological studies needed to lead to medical applications.
The concluding chapter will discuss the implications of this work to enable the fabrication of even more
sophisticated biomaterials.
5
1.5 References
[1] F. J. Schoen and R. N. Mitchell. Chapter II.1.5 - Tissues, the Extracellular Matrix, and Cell-Biomaterial
Interactions, pages 452–474. Academic Press, 2013.
[2] A. Page-McCaw, A. J. Ewald, and Z. Werb. Matrix metalloproteinases and the regulation of tissue
remodelling. Nat Rev Mol Cell Biol, 8(3):221–233, 2007.
[3] S. Huang and D. E. Ingber. The structural and mechanical complexity of cell-growth control. Nat Cell
Biol, 1(5):E131–E138, 1999.
[4] J. Pelham, R. J. and Y. Wang. Cell locomotion and focal adhesions are regulated by substrate flexibility.
Proc Natl Acad Sci U S A, 94(25):13661–5, 1997.
[5] A. J. Engler, S. Sen, H. L. Sweeney, and D. E. Discher. Matrix elasticity directs stem cell lineage
specification. Cell, 126(4):677–689, 2006.
[6] K. Ahle´n and K. Rubin. Platelet-derived growth factor-bb stimulates synthesis of the integrin alpha
2-subunit in human diploid fibroblasts. Exp Cell Res, 215(2):347–53, 1994.
[7] K. Ahle´n, P. Ring, B. Tomasini-Johansson, K. Holmqvist, K.-E. Magnusson, and K. Rubin. Platelet-
derived growth factor-BB modulates membrane mobility of β1 integrins. Biochem Bioph Res Co, 314
(1):89–96, 2004.
[8] J. Du, X. Chen, X. Liang, G. Zhang, J. Xu, L. He, Q. Zhan, X.-Q. Feng, S. Chien, and C. Yang. Integrin
activation and internalization on soft ECM as a mechanism of induction of stem cell differentiation by
ECM elasticity. Proceedings of the National Academy of Sciences, 108(23):9466–9471, 2011.
[9] C. S. Chen, M. Mrksich, S. Huang, G. M. Whitesides, and D. E. Ingber. Geometric control of cell life
and death. Science, 276(5317):1425–8, 1997.
[10] K. A. Kilian, B. Bugarija, B. T. Lahn, and M. Mrksich. Geometric cues for directing the differentiation
of mesenchymal stem cells. Proceedings of the National Academy of Sciences, 107(11):4872–4877, 2010.
[11] B. K. Mann, R. H. Schmedlen, and J. L. West. Tethered-TGF-beta increases extracellular matrix
production of vascular smooth muscle cells. Biomaterials, 22(5):439–44, 2001.
[12] M. Mrksich, C. S. Chen, Y. Xia, L. E. Dike, D. E. Ingber, and G. M. Whitesides. Controlling cell
attachment on contoured surfaces with self-assembled monolayers of alkanethiolates on gold. Proceedings
of the National Academy of Sciences, 93(20):10775–10778, 1996.
[13] K. B. Lee, S. J. Park, C. A. Mirkin, J. C. Smith, and M. Mrksich. Protein nanoarrays generated by
dip-pen nanolithography. Science, 295(5560):1702–5, 2002.
[14] A. Bernard, J. P. Renault, B. Michel, H. R. Bosshard, and E. Delamarche. Microcontact printing of
proteins. Advanced Materials, 12(14):1067–1070, 2000.
[15] J. T. Delaney, P. J. Smith, and U. S. Schubert. Inkjet printing of proteins. Soft Matter, 5(24):4866–4877,
2009.
[16] Y. Hong, P. Krsko, and M. Libera. Protein surface patterning using nanoscale PEG hydrogels. Langmuir,
20(25):11123–6, 2004.
[17] K. L. Christman, E. Schopf, R. M. Broyer, R. C. Li, Y. Chen, and H. D. Maynard. Positioning multiple
proteins at the nanoscale with electron beam cross-linked functional polymers. Journal of the American
Chemical Society, 131(2):521–527, 2009.
[18] G. Dorman and G. D. Prestwich. Benzophenone photophores in biochemistry. Biochemistry, 33(19):
5661–73, 1994.
6
[19] C. L. Hypolite, T. L. McLernon, D. N. Adams, K. E. Chapman, C. B. Herbert, C. C. Huang, M. D.
Distefano, and W.-S. Hu. Formation of microscale gradients of protein using heterobifunctional pho-
tolinkers. Bioconjugate Chemistry, 8(5):658–663, 1997.
[20] M. Y. Balakirev, S. Porte, M. Vernaz-Gris, M. Berger, J. P. Arie, B. Fouque, and F. Chatelain. Photo-
chemical patterning of biological molecules inside a glass capillary. Analytical Chemistry, 77(17):5474–9,
2005.
[21] W. W. Shen, S. G. Boxer, W. Knoll, and C. W. Frank. Polymer-supported lipid bilayers on
benzophenone-modified substrates. Biomacromolecules, 2(1):70–79, 2001.
[22] E. Delamarche, G. Sundarababu, H. Biebuyck, B. Michel, C. Gerber, H. Sigrist, H. Wolf, H. Ringsdorf,
N. Xanthopoulos, and H. J. Mathieu. Immobilization of antibodies on a photoactive self-assembled
monolayer on gold. Langmuir, 12(8):1997–2006, 1996.
[23] C. R. Toh, T. A. Fraterman, D. A. Walker, and R. C. Bailey. Direct biophotolithographic method for
generating substrates with multiple overlapping biomolecular patterns and gradients. Langmuir, 25(16):
8894–8898, 2009.
[24] T. A. Martin, C. T. Herman, F. T. Limpoco, M. C. Michael, G. K. Potts, and R. C. Bailey. Quantitative
photochemical immobilization of biomolecules on planar and corrugated substrates: a versatile strategy
for creating functional biointerfaces. ACS Appl Mater Interfaces, 3(9):3762–71, 2011.
[25] C. T. Herman, G. K. Potts, M. C. Michael, N. V. Tolan, and R. C. Bailey. Probing dynamic cell-
substrate interactions using photochemically generated surface-immobilized gradients: application to
selectin-mediated leukocyte rolling. Integrative Biology, 3(7):779–791, 2011.
[26] K. H. Stenzel, T. Miyata, and A. L. Rubin. Collagen as a biomaterial. Annual Review of Biophysics
and Bioengineering, 3(1):231–253, 1974.
[27] T. A. Martin, S. R. Caliari, P. D. Williford, B. A. Harley, and R. C. Bailey. The generation of biomolec-
ular patterns in highly porous collagen-GAG scaffolds using direct photolithography. Biomaterials, 32
(16):3949–3957, 2011.
7
Chapter 2
Bromelain Decreases Neutrophil
Interactions with P-Selectin In Vitro
by Proteolytic Cleavage of P-Selectin
Glycoprotein Ligand-1
This chapter has been adapted from the article “Bromelain Decreases Neutrophil Interactions with P-
Selectin, but Not E-Selectin, In Vitro by Proteolytic Cleavage of P-Selectin Glycoprotein Ligand-1” and used
here with permission from PLOS in accordance with the Creative Commons Attribution License © 2013.
The original article (Banks, J. M., Herman, C. T., and Bailey, R. C. PLoS ONE, 8(11):e78988, 2013.) can
be accessed online at http://dx.doi.org/10.1371/journal.pone.0078988.
This work was funded by the Roy J. Carver Charitable Trust, the Camille and Henry Dreyfus Foundation,
the National Science Foundation (DMR 11-05300), and a pre-doctoral fellowship from the National Institutes
of Health, National Center for Complementary & Alternative Medicine (Award Number F31AT006286). The
content is solely the responsibility of the authors and does not necessarily represent the official views of the
National Center for Complementary & Alternative Medicine or the National Institutes of Health. The
funders had no role in study design, data collection and analysis, decision to publish, or preparation of the
manuscript.
I acknowledge C. Herman for her equal contributions to the authorship of this paper. C. Herman
contributed fluorescence images, data from flow assays with E-selectin, radioimmunoassays, and all flow
cytometric analysis shown; I contributed P-selectin patterning, data from flow assays with P-selectin, all
western blotting, and flow cytometric analysis with exogenous P-selectin (not shown).
2.1 Abstract
Stem bromelain, a cysteine protease isolated from pineapples, is a natural anti-inflammatory treatment, yet
its mechanism of action remains unclear. Curious as to whether bromelain might affect selectin-mediated
leukocyte rolling, we studied the ability of bromelain-treated human neutrophils to tether to substrates
presenting immobilized P-selectin or E-selectin under shear stress. Bromelain treatment attenuated P-
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selectin-mediated tethering but had no effect on neutrophil recruitment on E-selectin substrates. Flow
cytometric analysis of human neutrophils, using two antibodies against distinct epitopes within the P-
selectin glycoprotein ligand-1 (PSGL-1) active site, revealed that bromelain cleaves PSGL-1 to remove one
of two sites required for P-selectin binding, while leaving the region required for E-selectin binding intact.
These findings suggest one molecular mechanism by which bromelain may exert its anti-inflammatory effects
is via selective cleavage of PSGL-1 to reduce P-selectin-mediated neutrophil recruitment.
2.2 Introduction
Inflammation is a complex physiological process involving numerous receptor-ligand interactions between
leukocytes and the endothelial lining of the blood vessel that ultimately lead to the trafficking of leukocyte
subsets throughout the body.1 Numerous diseases are associated with dysregulated inflammation, including
rheumatoid arthritis, asthma, psoriasis, thrombotic disorders, cancer, and autoimmune disease.2
Bromelain is a mixture of several cysteine proteases isolated from pineapple extracts, and is taken as a
complementary anti-inflammatory treatment.3 Bromelain is known to alter multiple cell surface molecules
involved in the adhesion and activation of leukocytes4 leading to anti-inflammatory, fibrinolytic, and anti-
thrombotic effects in vivo and in vitro.5–7 Previous reports have investigated the effects of bromelain treat-
ment on neutrophil migration in response to chemokines.4,8 However, bromelain’s ability to alter cell surface
molecules involved in the initial tethering and rolling of leukocytes on the inflamed endothelium has not
been investigated to date. Among the enzymes present in bromelain extract is stem bromelain, which was
used in this study and will be simply referred to as bromelain herein.
Endothelial-expressed P-selectin and E-selectin play central roles during the initiation of an inflammatory
response. When the endothelium receives distress signals from underlying tissue, P-selectin is the first
biomolecule deployed from intracellular storage pools to the luminal surface.9,10 The interaction between
P-selectin and its primary leukocyte-expressed ligand, P-selectin glycoprotein ligand-1 (PSGL-1), supports
neutrophil rolling along the surface of the blood vessel.11 E-selectin, which binds to PSGL-1 among other
ligands12 is also presented on the endothelium during the inflammatory response, but its expression is
largely controlled by translation13 and its presentation temporally lags behind that of P-selectin in vivo.9
Given these temporal selectin expression dynamics, we felt it would be beneficial to independently probe
bromelain’s effects on neutrophil interactions with substrates presenting each of these glycoproteins. To
achieve this, we utilized a photochemical surface modification strategy14 developed in our lab to generate
substrates presenting controlled densities of P-selectin or E-selectin15, and then used these substrates to
9
investigate the effect of bromelain treatment on the ability of human neutrophils to tether and roll in flow
assays (Figure 2.1).
Neutrophils are among the first responders that rapidly accumulate at sites of inflammation and thus a
potential key player in the initial steps of the immune response.16 Flow cytometric expression analysis of
two ligands involved in leukocyte recruitment mediated by P-selectin and E-selectin, PSGL-1 and cutaneous
lymphocyte antigen (CLA), respectively, was performed to determine the effects of bromelain treatment on
ligand expression. The results reveal a site-specific proteolysis through which bromelain treatment abolishes
interactions between neutrophils and immobilized P-selectin, but not E-selectin, under conditions of physi-
ological shear stress in vitro, suggesting another molecular mechanism through which bromelain may act as
an anti-inflammatory agent.
2.3 Results and discussion
Interestingly, we found that bromelain treatment of neutrophils nearly eliminated their ability to interact
with P-selectin presented on substrates in vitro, while E-selectin-mediated interactions are unaffected. The
observations from neutrophil flow assays were complemented by dose-dependent effects of bromelain treat-
ment on the expression of P-selectin and E-selectin ligands using flow cytometry. Our findings suggest that
the anti-inflammatory effects of bromelain may be attributed in part to its ability to proteolytically pro-
cess PSGL-1 and thereby reduce the number of cells interacting with P-selectin presented on the inflamed
endothelium during the initial phases of an inflammatory response.
Using a molecularly general method previously developed in our lab for the covalent and controllable
photochemical immobilization of biomolecules on planar glass substrates,14 we generated and character-
ized substrates presenting defined high and low levels of P- or E-selectin (Figure 2.1, Figure 2.2, and Fig-
ure 2.3). Substrates were characterized with fluorescence imaging and average fluorescence intensity values
were converted into biomolecule site densities using an established fluorescence-radioactivity correlation for
P-selectin15 and E-selectin (Figure 2.4).
Figure 2.5 shows neutrophil flow assay results using primary human neutrophils. For the first set of flow
assays, human neutrophils were isolated (>90% pure, >95% viable) and flowed at a constant shear stress
over substrates presenting immobilized P-selectin at high and low site densities. The number of interacting
cells was significantly reduced when neutrophils were treated with 50 µg/mL bromelain, compared to a
control sample (p<0.05). Incubation of control cells with saturating levels of a monoclonal antibody (mAb)
against PSGL-1, clone KPL-1, which recognizes an epitope encompassing three sulfated tyrosines in the
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active site of PSGL-1, similarly resulted in a decrease in the number of interacting cells, suggesting that
the decreased interactions are due to reduced PSGL-1 association with underlying P-selectin. In the case
of bromelain treatment, this is caused by proteolytic cleavage of PSGL-1 so as to remove the region of the
molecule required to engage P-selectin.
It is well established that PSGL-1 is the predominant and most well-characterized binding partner of
P-selectin.17 However, we wanted to validate the specific targeting of PSGL-1 by bromelain as an effector of
rolling and tethering on P-selectin substrates and therefore performed an additional control experiment. This
experiment utilized neutrophil-like HL-60 promyelocytes, which also tether and roll on P-selectin surfaces
via PSGL-1, and a monoclonal anti-PSGL-1 blocking antibody (clone KPL-1) with and without bromelain
treatment. As shown in Figure 2.6, treatment with the blocking antibody alone led to a marked decrease in
the number of tethering events on both high and low P-selectin substrates. Importantly, HL-60 cells that were
treated with bromelain after being blocked with the antibody did not show a further reduction in substrate
interaction, confirming the specific action of bromelain on PSGL-1 as it leads to reduced interactions with
P-selectin surfaces.
P-selectin is the primary molecular player that controls initial neutrophil interactions with the inflamed
endothelium; however E-selectin is also known to play a key role in mediating leukocyte rolling. PSGL-1 is
a ligand for both P- and E-selectin and therefore we wanted to see whether bromelain treatment similarly
abolished neutrophil interactions on E-selectin. Isolated human neutrophils were flowed over substrates
presenting two different site densities of immobilized E-selectin. In contrast to experiments on P-selectin-
presenting substrates, bromelain treatment had no significant effect on neutrophil tethering to immobilized
E-selectin. The cutaneous lymphocyte antigen (CLA) glycan moiety pendant on PSGL-118,19 and other
ligands20, plays a role in leukocyte tethering and rolling mediated by E-selectin19. To see if neutrophil
interactions with immobilized E-selectin could be altered by blocking CLA on all E-selectin ligands, we
incubated neutrophils with saturating levels of HECA-452, a widely used mAb that targets CLA. Not
surprisingly, this blocking antibody reduced tethering to immobilized E-selectin (Figure 2.5c-d), though the
effect was not as significant as that for the anti-PSGL-1 blocking on P-selectin substrates. The incomplete
inhibition of tethering on E-selectin after anti-CLA blocking reflects the fact that E-selectin, unlike P-
selectin, has a diverse range of potential binding partners and thus simply blocking one binding epitope
does not abolish all interactions, a finding consistent with the literature.21 Overall, neutrophil flow assays
with E-selectin-presenting substrates reveal that bromelain does not proteolytically abolish all interactions
between neutrophils and E-selectin. Importantly, the sulfated tyrosine residue epitope targeted by KPL-1 is
not required for recognition of PSGL-1 by E-selectin22 and so the unaffected interactions with this substrate
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after bromelain treatment is consistent with a molecularly specific cleavage of PSGL-1, but also supports
E-selectin recognition by ligands besides PSGL-1.
Neutrophils flowed across simple human serum albumin-blocked substrates, without P- or E-selectin,
showed no interactions which established that observed cell-substrate interactions were the result of specific
receptor-ligand interactions.
To further investigate the molecular mechanism by which bromelain treatment regulates the initial phases
of neutrophil tethering, we performed flow cytometric analyses to determine how expression of PSGL-1, which
binds to both P-selectin and E-selectin, is modulated by bromelain treatment. There are two distinct struc-
tural domains of PSGL-1 that are required for interactions with each of the selectins and our flow cytometric
analysis utilized two mAbs specific for these regions. Antibody KPL-1 recognizes a region that contains the
sulfated tyrosine motif required for interactions with P-selectin, but not E-selectin.22 This specificity was
previously demonstrated as incubation of leukocytes with the KPL-1 antibody completely blocked interac-
tions with P-selectin without affecting leukocyte recognition of E-selectin.23 Antibody CHO131 recognizes
a sialyl-Lewisx bearing a core 2 O-glycan that is required for interaction of neutrophils with both P-selectin
and E-selectin.24
Flow cytometric analysis using these antibodies suggests that bromelain is able to specifically cleave
PSGL-1 at a site in between the epitopes for clones KPL-1 and CHO131 (Figure 2.7). Analysis with clone
KPL-1 revealed that the level of the sulfated tyrosine motif is reduced by ∼80% as the dose of bromelain
exposure was increased from 0 to 100 µg/mL. However, analysis with clone CHO131 showed that the levels
of this epitope were not significantly decreased at all concentrations of bromelain tested. In fact, CHO131
epitope expression moderately increased at low bromelain concentrations before showing a slight decrease
at higher concentrations. While we do not completely understand the significance of this increase, it is
clear that bromelain is able to directly and dramatically attenuate the sulfated tyrosine motif needed for
P-selectin tethering while leaving significant expression of the sLex glycan needed for E-selectins interaction
with PSGL-1. Treatment of human neutrophils with deactivated bromelain had no significant effect on
neutrophil expression of PSGL-1 (Figure 2.8), suggesting that enzyme activity is required to induce the
changes in surface expression of PSGL-1 that we observed following treatment with active bromelain. The
molecularly-specific processing of PSGL-1 at a position that down-regulates interactions with P-selectin, yet
upstream of the sialyl-Lewisx bearing core 2 O-glycan structure involved in E-selectin interactions, suggests
that bromelain may selectively affect the very initial phases of neutrophil recruitment.
As additional verification of PSGL-1 processing by bromelain, we performed Western blot analysis of
the protein after exposure to the enzyme. Figure 2.9 compares the 100-150 kDa band of an immunoblot
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of untreated PSGL-1 and PSGL-1 treated with bromelain. When probed with a polyclonal antibody, no
statistically significant difference in intensity was observed but an overall reduction in molecular weight was
apparent. When visualized by staining with anti-PSGL-1 clone KPL-1, which recognized the N-terminal
portion of the protein that present the sulfated tyrosine residues, there was a significant reduction in the
band intensity for bromelain treatment compared to the untreated sample (p<0.05). These results are
consistent with flow cytometry analysis that showed a marked reduction in the N-terminal component of
PSGL-1 using the same antibody clone. As a control, human IgG1 Fc was left untreated or treated identically
with bromelain and immunoblotted alongside the PSGL-1 Fc chimera. In both blots, no bands were observed
in either IgG1 Fc lanes, confirming that changes in PSGL-1 band intensity are not due to interference from
the Fc chimera portion of the recombinant protein.
We also determined the effects of bromelain treatment on expression levels of CLA, a carbohydrate
epitope shared by sialyl-Lewisx and sialyl-Lewisa structures that has been found to be present on PSGL-1
and other E-selectin ligands.20 To characterize CLA expression on neutrophils, we used clone HECA-452,
and this analysis revealed that CLA expression declines in a nearly linear fashion by up to 20% as the dose
of bromelain increases from 0 to 100 µg/mL (Figure 2.10). Similar to flow cytometry analysis of PSGL-1
expression, treatment of human neutrophils with deactivated bromelain caused no significant changes in the
surface levels of CLA (data not shown).
In this study we used a combination of molecular biology and controlled chemical surface modification
to reveal new insight into one potential molecular mechanism by which bromelain can regulate immune
response. We found that bromelain cleaves PSGL-1, P-selectins primary ligand that is involved in the
onset of selectin-mediated leukocyte rolling during inflammation, resulting in the attenuation of neutrophil
recruitment on immobilized P-selectin, but not E-selectin, in vitro. While the levels of bromelain utilized in
this study are higher than that known to be achievable in serum, previous studies on the effects of bromelain
treatment on leukocyte migration and inflammation established the value of in vitro assays using similarly
high relative bromelain concentrations.4,5 Therefore the basic mechanistic insight gleaned from this study,
as well as future efforts to understand neutrophil-selectin interactions both in vitro and in vivo, may reveal
additional key insights into the molecular mechanism underlying bromelains anti-inflammatory properties.
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2.4 Methods
2.4.1 Ethics statement
Blood was obtained from healthy adults who gave informed consent. Written consent was obtained and
recorded from all volunteers. This protocol and consent procedure was approved as “Isolation of human
blood cells for rolling and adhesion studies and molecular analysis” by the Institutional Review Board at
the University of Illinois at Urbana-Champaign entitled (IRB #11117).
2.4.2 Materials
All chemicals were purchased from Sigma-Aldrich, unless otherwise noted.
2.4.3 Photochemical immobilization of P-selectin or E-selectin on glass
substrates
Substrates presenting two regions of distinct site densities of immobilized P-selectin or E-selectin were
prepared using a previously reported photopatterning method.14 Briefly, cleaned glass microscope slides were
functionalized with 4-(triethoxysilyl)butyl aldehyde (Gelest), incubated with 20 mM 4-benzoyl benzylamine
hydrochloride (Matrix Scientific) and 200 mM NaCNBH3, followed by immersion in aldehyde-blocking buffer
(200 mM ethanolamine, 0.1 M Tris, pH 7), rinsing water, methanol, and ethanol. P-selectin and E-selectin
(R&D Systems) were freshly diluted to 2.5 µg/mL from concentrated stocks into PBS with Ca2+ and Mg2+
(Sigma). BP-modified substrates were assembled into a rectangular parallel-plate flow chamber (GlycoTech)
with a silicone gasket (127 µm thickness). Protein photoimmobilization was enabled through the use of an
Ar ion laser (Coherent Innova 90-4, Laser Innovations, 351.1-363.8 nm), whose Gaussian beam profile was
converted to a flat-top profile using a -Shaper (MT-Berlin), and expanded to a 1 cm2 area using beam-
expanding optics (ThorLabs, 14 mW/cm2). At least six replicate substrates were generated presenting
areas of high (650-750 molecules/µm2) and low (250-400 molecules/µm2) protein site density by exposing
two distinct regions of each substrate for 3 or 30 seconds (for P-selectin) and for 6 or 60 seconds (for E-
selectin). Substrates for flow assays were stored in 0.5% human serum albumin (HSA) in Hanks Buffered
Saline Solution with Ca2+ and Mg2+ and 10 mM HEPES (pH 7.4, HBSS/HEPES) until use, while the
remaining replicate substrates were incubated with fluorescently labeled antibodies and visualized with a
fluorescence slide scanner (Figure 2.3, GenePix 4000B, MDS Analytical Technologies), as previously reported
for P-selectin.15 Data for E-selectin quantitation was obtained for this study (Figure 2.4).
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2.4.4 Neutrophil flow assays on substrates presenting P-selectin and E-selectin
Substrates presenting P-selectin or E-selectin (Figure 2.2 and 2.3) were utilized in flow assays with human
neutrophils using a previously described methodology,15 shown schematically in 2.1. Human neutrophils
were isolated from whole blood by density centrifugation using Ficoll-Paque, followed by selection with Easy-
Sep Human Neutrophil Enrichment Kit (STEMCELL Technologies). Neutrophil viability was determined
with trypan blue staining. Neutrophil purity was determined by flow cytometry using two fluorescently
labeled antibodies against neutrophil surface markers CD16 and CD66b (STEMCELL Technologies, Fig-
ure 2.11). One sample was resuspended in a solution of 50 µg/mL bromelain in RPMI, and the other
two samples were resuspended in RPMI. All samples were incubated for 30 min at 37 C, washed with
HSA/HBSS/HEPES, and pelleted for 5 min at 500 rcf. One of the RPMI-treated neutrophil samples was
resuspended in 30 µg/mL anti-PSGL-1 (clone KPL-1) or anti-CLA (clone HECA-452) and incubated at
room temperature for 30-60 min before being diluted to 0.5×106 cells/mL for flow assay experiments. The
remaining cell pellets were immediately resuspended in HBSS/HEPES with 0.5% HSA to 0.5×106 cells/mL.
All samples were used in flow assay experiments within 2-3 hours of isolation.
Neutrophils were introduced into the chamber at 3 mL/min (9.3 dyn/cm2) for 1 min, then the flow rate
was dropped to 400 L/min (1.28 dyn/cm2). After 1 min, 20-30 sec videos were acquired at 4-5 positions in
each area of the substrate. Neutrophils from three donors were used to perform independent experiments on
three replicate substrates for each protein. For each substrate, the number of new tethers formed per unit
area and time was determined by counting the number of cells that interacted with the surface. Cells that
were already rolling or adhered upon the surface were not included in the analysis. HSA-blocked BP-modified
substrates were used as control substrates to verify that the observed interactions were due to neutrophil
interactions with immobilized P-selectin or E-selectin.
2.4.5 Differentiated HL-60 flow assays on substrates presenting P-selectin
HL-60 promyelocytes (ATCC) were differentiated for 6 days following addition of 1.3% dimethyl sulfox-
ide. Cell viability and treatment with RPMI, bromelain, or anti-PSGL-1 (clone KPL-1) was performed as
described above for neutrophil flow assays. For double treatment with bromelain and anti-PSGL-1 (clone
KPL-1), the sample was resuspended in 30 µg/mL antibody and incubated at room temperature for 10 min
before incubation with bromelain for 30 min at 37°C. Flow chamber assays were performed as described for
neutrophils on three replicate P-selectin substrates. Flow cytometric analysis of bromelains effect on cell
surface molecules Human neutrophils were isolated from whole blood as described above. Neutrophils were
prepared for analysis of expression of PSGL-1 and CLA following treatment with 0, 10, 25, 50, or 100 µg/mL
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bromelain in RPMI cell culture medium for 30 min at 37 °C. In some experiments, an additional aliquot of
cells were treated with chemically deactivated bromelain, which was prepared by reacting bromelain with
dithiothreitol and iodoacetamide, followed by treatment with a proteinase cocktail inhibitor solution con-
taining E-64, according to manufacturers protocols. Following incubation with bromelain or RPMI, cells
were washed with HSA/HBSS/HEPES and were pelleted for 5 min at 500 rcf. Neutrophils were then blocked
for 15 min with 3% HSA in HBSS/HEPES and incubated for 30 min with primary monoclonal antibodies
and fluorescently labeled secondary antibodies at final concentrations of 20 and 10 µg/mL, respectively. For
detection of cell-surface PSGL-1, we used mouse anti-human PSGL-1 clone KPL-1 (Millipore), and mouse
anti-human PSGL-1 clone CHO131 (R&D Systems). For detection of CLA, clone HECA-452 (BioLegend)
was used. For all samples, we used secondary antibody PE-conjugated goat anti-mouse IgG (Invitrogen).
Control samples were incubated with the PE-labeled secondary antibody alone. Solutions composed of pri-
mary and secondary antibodies were preincubated for at least 1 hr prior to incubation with cells. Cells were
analyzed with a BD FACSCanto II cytometer (BD Biosciences). Fluorescence data from neutrophil popula-
tions were plotted in histogram form (FCS Express, BD Biosciences), and the average fluorescence intensity
from each sample was plotted as the percentage of the antigen expression relative to the RPMI-treated
sample as a function of bromelain concentration.
2.4.6 Western blot analysis of proteolytic processing of recombinant PSGL-1
by bromelain
Equimolar amounts of recombinant human PSGL-1 Fc chimera (R&D Systems) or recombinant human IgG1
Fc (R&D Systems) were treated with bromelain at a final concentration of 10 µg/mL for 30 minutes at 37
°C. PSGL-1 was left untreated under the same conditions. Samples were electrophoresed on a 4-20% SDS-
polyacrylamide gel (Bio-Rad) and immunoblotted on PVDF membranes (Millipore). The 100-150 kDa band
of PSGL-1 (consistent with manufacturer specifications) was visualized with anti-PSGL-1 antibody clone
KPL-1, which recognizes the sulfated tyrosine residues near the N-terminus, or a polyclonal PSGL-1 antibody
(R&D Systems). After incubation with relevant secondary HRP-linked antibody, the blot was visualized
using enhanced chemiluminescent substrate (Pierce). Digital images were taken using an ImageQuant LAS
4010 biomolecular imager (GE) and analyzed using ImageQuant TL software (GE).
2.4.7 Statistical Analysis
Groups were compared using one-way ANOVA with Tukeys HSD test for post-hoc comparison of more than
two groups. For western blot data in 2.9c, students unpaired t test was used to compare results. Data were
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analyzed with GraphPad Prism software and p-values are provided.
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2.5 Figures
Figure 2.1: Substrates for cell interactions studies were fabricated via direct, photochemical functionalization.
Glass slides chemically-modified to present benzophenone moieties were immersed in a solution containing
the protein of interest—here P- or E-selectin. Photoimmobilization is initiated by exposure to 365 nm
light, which results to covalently bound protein through a radical generation mechanism. Importantly,
the density of immobilized protein can be systematically defined by carefully controlling the exposure time.
Substrates, prepared in batches, were then subsequently used to quantify deposition density (via fluorescence
or radioimmunoassay) or utilized to study the effects of bromelain treatment on primary human neutrophil-
selectin interactions.
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Figure 2.2: Fluorescence images and plots of average site density from substrates presenting photoimmo-
bilized selectins. (a) Sites densities for P-selectin substrates were determined using a previously reported
radioimmunoassay15. (b) A similar radioimmunoassay for E-selectin ( 2.3) was used to determine site den-
sities of E-selectin substrates. Scale bar = 1 mm.
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Figure 2.3: Average fluorescence intensity and site density determination for P-selectin and E-selectin sub-
strates. Substrates were incubated with fluorescently labeled antibodies, and fluorescence intensity units
were converted to site density (molecules/µm2) using previous reported calibration curves.15
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Figure 2.4: The relationship between fluorescence intensity and site density was determined for photoimmo-
bilized E-selectin on BP-modified substrates. Substrates were generated in triplicate via flood UV exposures
in the presence of protein solution, resulting in homogeneous substrates presenting a wide range protein
site density levels. Fluorescence measurements were acquired after incubating substrates with fluorescently
labeled antibodies. Briefly, we generated six replicate substrates presenting varying levels of immobilized
E-selectin in a defined area on BP-modified substrates and split the substrates into two groups: one group
for fluorescence analysis and the other for radioactivity analysis. For site density determination, substrates
were incubated with saturating concentrations of primary monoclonal antibody (mAb) and [125I]-labeled
secondary polyclonal antibody (pAb). Control substrates were used to account for non-specific mAb and
pAb binding. The data from both studies were correlated to determine the relationship between fluorescence
intensity and site density for each protein. Using the equation from the linear regression for the resulting
calibration curve, immobilized E-selectin substrates were quantified by converting data from fluorescence
analyses to site density. Data is plotted as the average (± 95% C.I.) for n=3 substrates.
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Figure 2.5: Data from flow assays with neutrophils treated with RPMI or bromelain. Bromelain attenuates
neutrophil tethering on immobilized P-selectin but has no effect on E-selectin-mediated tethering. (a)
Snapshots from representative flow assay videos show neutrophils interacting with substrates presenting
immobilized P-selectin. Arrows point to cells interacting with the substrate under conditions of shear stress.
(b) Data from primary human neutrophil flow assays with P-selectin substrates reveal that the number of
interacting cells is decreased when neutrophils are treated with 50 µg/mL bromelain in RPMI on regions
of “high” and “low” immobilized P-selectin. (** p<0.05) Treatment with saturating levels of anti-PSGL-1
clone KPL-1 significantly decreased P-selectin mediated tethering on high P-selectin substrates (** p<0.05).
(c) Snapshots from representative flow assay videos show neutrophils interacting with substrates presenting
immobilized E-selectin with arrows indicating interacting cells. (d) Data from primary human neutrophil
flow assays with E-selectin substrates reveal that the number of interacting cells is not significantly affected
when neutrophils are treated with 50 µg/mL bromelain in RPMI on regions of “high” or “low” immobilized
E-selectin. Treatment with saturating levels of anti-CLA clone HECA-452 had no significant effect on
neutrophil tethering to immobilized E-selectin. Neutrophils failed to interact with HSA-blocked control
substrates. Data represent the average of n=3 donors (±SEM). Scale bar: 80 µm.
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Figure 2.6: Blocking of PSGL-1 with a monoclonal anti-PSGL-1 antibody prevents subsequent proteolytic
cleavage by bromelain thereby preventing further reduction in tethering on P-selectin. Data from flow assays
with differentiated HL-60 promyelocytes treated with bromelain, blocking antibody, both, or untreated.
For both “high” (*** p<0.001) and “low” (* p<0.10) P-selectin substrates, bromelain, blocking antibody,
and combination treatments reduced substrate interactions. In both cases, combination treatment did not
significantly further reduce interactions beyond that of bromelain treatment alone. Data represent the
average of n=3 independent P-selectin substrates (±SEM).
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Figure 2.7: Flow cytometric analysis reveals bromelain cleaves PSGL-1 within its active site in a dose-
dependent manner. To analyze neutrophil expression of PSGL-1, the primary ligand for P-selectin, we
used two anti-PSGL-1 antibodies that recognize distinct structural motifs within the PSGL-1 active site.
(a) Representative data from an analysis with clone KPL-1 reveals an 80% decrease in PSGL-1 expression
following treatment with 100 µg/mL bromelain. (b) Representative data from an analysis with clone CHO131
reveals a slight increase followed by a decrease in PSGL-1 expression back to initial levels as bromelain
concentrations increase from 0 to 100 µg/mL. (c) The average PSGL-1 expression levels of neutrophils from
n=3-4 donors (±SEM) plotted as a function of bromelain concentration, suggesting that bromelain cleaves
PSGL-1 at a position between the two epitopes recognized by the site-specific antibodies.
Figure 2.8: Flow cytometry analysis of PSGL-1 and CLA expression on neutrophils treated with RPMI or
deactivated bromelain reveals that deactivated bromelain (1000 µg mL-1) has no significant effect on PSGL-1
or CLA expression levels. Data presented is from 2 or 3 donors, and has been normalized to account for
differences in the flow cytometry instrument parameters used in each analysis.
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Figure 2.9: Bromelain proteolytically cleaves PSGL-1. Western blot analysis of untreated PSGL-1 and
PSGL-1 treated with bromelain. (a) Western blot probed with a polyclonal antibody recognizing PSGL-1
reveals a decrease in molecular weight after treatment with bromelain. (b) Western blot probed with antibody
KPL-1 after treatment with bromelain reveals a 39% decrease in the amount of PSGL-1 corresponding
to cleavage of the KPL-1 epitope. (c) Quantification of band intensity shown in figure 2.9b reveals that
bromelain treatment significantly reduces PSGL-1 band intensity (*** p<0.001). Data are expressed as the
mean ±SD of n=4 replicates. Data are representative of results obtained in three independent experiments.
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Figure 2.10: Flow cytometric analysis of CLA levels on human neutrophils following bromelain treatment.
(a) Representative data from an analysis with anti-CLA clone HECA-452 reveals a slight decrease in PSGL-
1 expression as bromelain concentration increases from 0 to 100 µg mL-1. (b) A plot of the average CLA
expression levels of n=6 donors (±SEM) following bromelain treatment ranging from 0 to 100 µg mL-1
reveals that bromelain causes average CLA expression to decrease by ∼20%.
Figure 2.11: Flow cytometry analysis of human neutrophils for neutrophil markers (a) CD66b and (b)
CD16 revealed >90% neutrophil purity in all cell samples isolated for neutrophil flow assay experiments
(representative data shown). Neutrophils were isolated using traditional Ficoll-Paque density centrifugation
followed by magnetic bead separation. Control sample (black) were incubated with fluorescently labeled
isotype control antibodies.
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Figure 2.12: Bromelain proteolytically cleaves PSGL-1. SDS-PAGE analysis and silver staining of untreated
PSGL-1 and PSGL-1 treated with bromelain reveals that bromelain treatment decreases the observed molec-
ular weight.
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Chapter 3
The Combined Effects of Matrix
Stiffness and Growth Factor
Immobilization on the Bioactivity and
Differentiation Capabilities of
Adipose-Derived Stem Cells
This chapter has been adapted from the article “The combined effects of matrix stiffness and growth fac-
tor immobilization on the bioactivity and differentiation capabilities of adipose-derived stem cells” and
used here with permission from Elsevier © 2014. The original article (Banks, J. M., Mozdzen, L. C.,
Harley, B. A. C., and Bailey, R. C. Biomaterials, 35(32):8951-8959, 2014.) can be accessed online at
http://dx.doi.org/10.1016/j.biomaterials.2014.07.012.
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3.1 Abstract
Biomaterial designs are increasingly incorporating multiple instructive signals to induce a desired cell re-
sponse. However, many approaches do not allow orthogonal manipulation of immobilized growth factor
signals and matrix stiffness. Further, few methods support patterning of biomolecular signals across a bio-
material in a spatially-selective manner. Here, we report a sequential approach employing carbodiimide
crosslinking and benzophenone photoimmobilization chemistries to orthogonally modify the stiffness and
immobilized growth factor content of a model collagen-GAG (CG) biomaterial. We subsequently examined
the singular and combined effects of bone morphogenetic protein (BMP-2), platelet derived growth factor
(PDGF-BB), and CG membrane stiffness on the bioactivity and osteogenic/adipogenic lineage-specific gene
expression of adipose derived stem cells, an increasingly popular cell source for regenerative medicine stud-
ies. We found that the stiffest substrates direct osteogenic lineage commitment of ASCs regardless of the
presence or absence of growth factors, while softer substrates require biochemical cues to direct cell fate.
We subsequently describe the use of this approach to create overlapping patterns of growth factors across
a single substrate. These results highlight the need for versatile approaches to selectively manipulate the
biomaterial microenvironment to identify synergies between biochemical and mechanical cues for a range of
regenerative medicine applications.
3.2 Introduction
The development of biomaterial tools for a range of tissue engineering applications increasingly relies on
the coordinated presentation of multiple instructive signals. These efforts are often inspired by the native
extracellular matrix (ECM), where cells receive cues from an assortment of solution phase1–9 and substrate-
supported stimuli10–15. The ECM is a complex biomolecular network secreted by cells that serves as a
mechanical and structural support within which biomolecular cues can be presented in spatially16–19 and
temporally20,21 defined manners. Given the regulatory role played by the ECM in a multitude of impor-
tant processes such as tissue development22 and repair19,23, it is not surprising biomaterials platforms are
increasingly trying to regulate the coordinated presentation of multiple classes of ECM-inspired signals.
However, untangling the interactions between mechanical and biochemical cues is often complicated. New
approaches are needed to both elucidate the effects of and then recapitulate the functional properties of such
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complicated in vivo microenvironments.
In the context of musculoskeletal regeneration, a wide range of studies have concentrated on coordinated
presentation of biomolecular signals. Efforts initially focused on presenting a bioactive dose of a given single
factors (tenogenesis: IGF-13,24,25, PDGF9, GDF-526, bFGF7,27,28; osteogenesis: BMP-229,30; angiogene-
sis: VEGF31,32). Our previous work using collagen-GAG biomaterials demonstrated enhanced tenocyte
chemotaxis (via IGF-1) and proliferation (via PDGF-BB) in a dose dependent manner3. Moving towards
more complex tissue injuries, Thomopoulos et al. demonstrated single factor (BMP-2) supplementation
can promote healing at the tendon-bone interface30. More recently, efforts have begun to explore the po-
tential of coordinated presentation of multiple cues1,2,6,8. Borselli et al. showed a synergistic response in
muscle cells with combined delivery of angiogenic and myogenic growth factors1. We previously reported
advantages of coordinated growth factor presentation for promoting phenotypic stability and proliferation6,
but also found unintended consequences of multi-factor supplementation in the context of MSC-guided re-
generative medicine applications33. There are often trade-offs in stem cell proliferation and differentiation,
which suggests that multiple cues may need to work in tandem to elicit the desired response. Notably, Tan
et al. demonstrated that GDF-5 induced tenogenic differentiation in MSCs without negatively impacting
proliferation26, while other studies have looked at multiple cues to promote proliferation (i.e. PDGF) and
tenogenesis simultaneously9,34.
While solution phase supplementation in the media is the most straightforward method to provide in-
structive biomolecular cues in vitro, it is limited by diffusion and a lack of spatial localization. Inspired
by the biomolecular tethering to the native ECM, recent efforts have suggested that immobilized growth
factors can enhance bioactivity. A range of methods (e.g., carbodiimide cross-linking12,29,35, biotin-avidin
linkages36, and ’click’ chemistries37) have recently been reported for covalently attaching growth factors to
collagen-based scaffolds. However, these approaches did not include the ability to control the spatial distri-
bution of these biomolecules. In addition, the same cross-linking techniques which are used to immobilize
growth factors can also increase biomaterial stiffness. However, biomaterial mechanical properties can have
both direct and indirect effects on cell, and particularly MSC, response. The mechanical properties of the
matrix are also known to play profound roles impacting cell fate, with a range of stem cells showing partic-
ular sensitivity to mechanical stiffness38–43, making it potentially difficult to assess the individual impact of
matrix-immobilized growth factors.
Increasing evidence suggests that mechanical and biomolecular signals may act in a more coordinated
manner. Recently Allen et al. reported that matrix stiffness differentially primed the TGF-β signaling path-
way in the context of MSC-chondrogenesis44, suggesting the mechanical stiffness of the environment impacts
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how sensitive a cell may be to an exogenous factor. Further, Zouani et al. and Tan et al. both demonstrated
different types of coordinated responses for MSCs to matrix stiffness and BMP-2 presentation40,45. Notably,
Zouani et al. demonstrated a minimum stiffness (3.5 kPa) for MSCs to be responsive to BMP-2 with no
synergy between matrix stiffness and BMP-2 dose40, while Tan et al. reported a synergetic effect of ma-
trix stiffness and BMP-245; however in this case, matrix stiffness was modified via hydrogel density, which
likely significantly altered the microstructural cues presented to the cells. Both of these studies support the
contention that MSCs integrate multiple extrinsic signals in the context of fate decisions46–48. However,
these reports also motivate the development of new classes of biomaterials able to orthogonally modify ma-
trix structure, stiffness, and biomolecule incorporation, as well as approaches that are amenable to spatial
control over biomolecule incorporation, in order to better control stem cell differentiation and proliferation.
Such platforms offer unique potential for the field of tissue engineering and regenerative medicine to more
efficiently and effectively utilize structural, mechanical, and biomolecular signals that have yet to be fully
realized.
Herein we report a strategy that allows for independent manipulation of the mechanical properties and
spatially controlled presentation of biomolecular cues using a collagen-GAG (CG) biomaterial platform. CG
biomaterials have been used for a range of soft (e.g., skin, peripheral nerve)49–51 and hard/musculoskeletal
(e.g., bone, cartilage, tendon)52–54 tissue engineering applications, making them an attractive target for
technologies to selectively incorporate exogenous biomolecular signals. We have recently demonstrated
approaches to orthogonally modify the microstructural3 and mechanical55 properties of, as well as ap-
proaches to transiently20 or covalently6,56 modify growth factor presentation within these CG biomaterials.
Here we build on a previously reported benzophenone (BP) photolithography approach to spatially con-
trol immobilization of biomolecules to a CG biomaterial57. In this work, we explore the integration of a
separate crosslinking approach to allow orthogonal manipulation of matrix stiffness of the density of immo-
bilized biomolecular signals (BMP-2, PDGF-BB). We subsequently describe the individual and combined
impacts of matrix mechanical (elastic modulus) cues and immobilized BMP-2/PDGF-BB growth factors on
adipose-derived mesenchymal stem cell (ASC) bioactivity. This combined technological approach provides
an enabling platform to map synergies between multiple biochemical and mechanical cues across a single
biomaterial platform for a range of tissue engineering applications.
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3.3 Materials and methods
All reagents were purchased from Sigma-Aldrich (St. Louis, MO) unless otherwise noted. Phosphate buffered
saline buffer (PBS) was reconstituted and pH adjusted to 7.4.
3.3.1 Preparation of CG membranes
CG membranes were prepared via a previously described evaporative process58,59. Briefly, a CG suspension
was prepared from type I collagen (1.0% w/v) isolated from bovine Achilles tendon and chondroitin sulfate
(0.1% w/v) derived from shark cartilage in 0.05 M acetic acid. The suspension was homogenized at 4 °C
to prevent collagen gelatinization during mixing49. The CG suspension was degassed, pipetted into a petri
dish, and allowed to evaporate under ambient conditions to produce a film. Circular membrane specimens
(8 mm dia.) were cut using a biopsy punch (Integra-Miltex, York, PA) and stored in a desiccator until use.
3.3.2 Chemical crosslinking of CG membranes to modulate stiffness
Prior to use, CG membranes were hydrated in ethanol followed by PBS. They were subsequently crosslinked
using carbodiimide chemistry35,55 for 1 hour in a solution of 1-ethyl-3-[3-dimethylaminopropyl]carbodiimide
hydrochloride (EDC) and N-hydroxysulfosuccinimide (NHS) at molar ratios of 1:1:5, 5:2:5, 5:20.7:1, 5:2:1
EDC:NHS:COOH where COOH represents the amount of collagen in the scaffold35,55. A control group of
membranes were not cross-linked (NX). After crosslinking, membranes were rinsed and stored in PBS until
further use.
3.3.3 Covalent immobilization of growth factors via benzophenone
photolithography
Benzophenone (BP) was immobilized to the CG membrane using a previously described approach57,60.
Briefly, benzophenone-4-isothiocyanate was synthesized as previously reported61 and dissolved in dimethyl
formamide (DMF) to a final concentration of 20 mM. To that solution, N,N-diisopropylethylamine was added
to a final concentration of 0.5 M. CG membranes were submerged in this solution and allowed to react for
48 hours protected from light. Membranes were then rinsed in DMF, ethanol, and PBS to remove unreacted
benzophenone reagent, and subsequently stored in PBS at 4 °C in the dark until use57.
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3.3.4 Biomolecular photoimmobilization
Stock solutions of bone morphogenetic protein 2 (BMP-2, R&D Systems, Minneapolis, MN) and platelet
derived growth factor BB (PDGF-BB, R&D Systems) were prepared according to the manufacturers instruc-
tions and stored at −20 °C until use. In preparation for patterning, CG membranes were soaked in a solution
containing 5 µg/mL protein (PDGF-BB or BMP-2) in PBS. Membranes were subsequently transferred to a
glass slide, covered with a glass coverslip, and exposed to 20 mW/cm2 of 365 nm light provided by a beam of
an argon ion laser (Coherent Innova 90-4 with UV optics, Laser Innovations, Santa Paula, CA) that had been
expanded and homogenized using refractive beam shaping optics (pi-Shaper, Molecular Technologies, Berlin,
Germany). Membranes were exposed for a defined time (1 or 5 minutes). After UV exposure, membranes
were rinsed in a solution of 0.2% pluronic F-127 in PBS. For patterning multiple proteins, membranes were
further rinsed in PBS then soaked in the second protein solution and subsequently irradiated as described
above. After patterning, membranes were stored in PBS at 4 °C until use.
3.3.5 Fluorescent visualization of biomolecular patterns
In order to visualize biomolecule attachment, membranes containing immobilized proteins were transferred
into a solution of 1% bovine serum albumin (BSA) in PBS to block non-specific antibody binding. A rabbit
anti-PDGF-BB antibody (AbCam, Cambridge, MA) was pre-incubated with Alexa Fluor 647-conjugated
goat anti-rabbit IgG (Invitrogen, Carlsbad, CA) at a concentration of 1 µg/mL in 1% BSA-PBS. Similarly, a
rabbit anti-BMP-2 antibody (AbCam) was pre-incubated with Alexa Fluor 647-conjugated goat anti-rabbit
IgG (Invitrogen) at a concentration of 1 µg/mL in 1% BSA-PBS. Membranes were placed in the relevant
antibody staining solutions overnight at 4 °C, after which they were rinsed for at least 1 hour in PBS
and visualized using a fluorescence slide scanner (Axon Instruments-Molecular Devices, Sunnyvale, CA).
Total immobilized protein was estimated using a calibration curve generated from known concentrations of
factor57,62.
3.3.6 Mechanical characterization
Tensile mechanical tests were performed on hydrated CG membranes (10 mm gauge length x 6 mm wide;
0.6 mm thickness,) at a rate of 1.0 mm/min using a Bose Electroforce BioDynamic 5110 with a 1000 g load
cell. Data was collected with Bose WinTest software. The elastic modulus was calculated from the linear
region of the stress-strain curve for each sample.
35
3.3.7 Culture of adipose-derived mesenchymal stem cells and CG membrane
seeding
ASCs were isolated according to published procedures63 and stored in liquid nitrogen until use. Two million
ASCs were thawed and plated in 75 cm2 tissue culture flasks at a density of 6,000 to 7,000 cells/cm2
containing high glucose Dulbeccos Modified Eagles Medium (DMEM) supplemented with 10% fetal bovine
serum, 1% penicillin g-streptomycin, and 5.0 mg/L amphotericin B. Cells were expanded at 37 °C and 5%
CO2, with the culture medium changed every 3 days. Cells were rinsed with PBS and harvested using 0.25%
trypsin-EDTA followed by addition of an equal volume of complete medium. ASCs were centrifuged at 200
g for 5 minutes and resuspended to a concentration of 1×105 cells per 20 µL in DMEM. Cells were seeded
onto the CG membranes using a previously described static seeding method3. Briefly 10 µL of cell-laden
media was pipetted onto one side of each CG membrane in ultra-low attachment 6-well plates (Corning Life
Sciences, Lowell, MA) and incubated at 37 °C with 5% CO2 for 30 minutes. Membranes were flipped and
the remaining 10 µL of cells was added to the membrane. After 30 minutes of incubation at 37 °C to allow
cell attachment, 5 mL of complete DMEM was added to each well. The culture medium was changed every
3 days.
3.3.8 Quantifying cell attachment and proliferation
Total number of cells attached to the CG membranes were monitored using Hoechst 33258 dye (Invitrogen,
Carlsbad, CA) which fluorescently labels double-stranded DNA64. Total cell number was determined at
day 0 (initial cell attachment) as well as days 1, 4 and 7 (subsequent proliferation) using a fluorescence
spectrophotometer (Tecan Group Ltd., Mnnedorf, Switzerland)
3.3.9 Characterizing cell bioactivity
The mitochondrial metabolic activity of ASCs seeded on the CG membranes were quantified via alamarBlue
(Invitrogen)65. Membranes were incubated in the alamarBlue solution with gentle shaking for 1 hour. Viable
cells reduce the resazurin in the alamarBlue solution to resorufin, which produces fluorescence. Fluorescence
was measured (excitation 540 nm, emission 580 nm) on a fluorescent spectrophotometer (Tecan). Results
were compared to a prepared standard to compute equivalent cell number. Results (n = 3/timepoint) were
reported as the relative metabolic activity compared to the number of originally seeded cells.
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3.3.10 RNA isolation, cDNA synthesis, and quantitative real time polymerase
chain reaction
The expression of osteogenic, adipogenic, and matrix synthesis markers was determined via qPCR using
previously described methods52,66. Membranes were rinsed in PBS to remove unattached cells. Total
RNA was isolated using the RNeasy plant kit (Qiagen Inc., Valencia, CA) and converted to cDNA using
a QuantiTect reverse transcription kit (Qiagen Inc., Valencia, CA), both according to the manufacturers
instructions. Gene expression profiles were determined for Alkaline phosphatase (ALP), type 1 collagen
alpha-1 (COL1A1), osteocalcin (OCN), and peroxisome proliferator-activated receptor gamma (PPARG),
with glyceraldehyde 3-phosphate dehydrogenase (GAPDH) used as a housekeeping gene. Previously vali-
dated primer sequences were chosen from the literature (Table 3.1) and purchased from Integrated DNA
Technologies (Coraville, IA). Gene expression profiles were determined via three independent replicates of
each experimental condition by quantitative real-time polymerase chain reaction (qRT-PCR). qRT-PCR was
performed using a 7900HT Fast Real-Time PCR System (Applied Biosystems, Foster City, CA). The cDNA
was amplified according to the following conditions: 50 °C for 2 minutes and 95 °C for 10 minutes, then 95
°C for 15s and 60 °C for 60s for 40 amplification cycles. Amplification was monitored by SYBR Green and
a dissociation melting curve was performed to confirm a single PCR product. Results were analyzed using
SDS Software and the transcripts of interest were normalized to the housekeeping gene GAPDH. Relative
fold change (fold ∆) was calculated using the delta-delta Ct method.
3.3.11 Statistical analysis
One-way analysis of variance (ANOVA) was performed on biomolecular immobilization data (Figure 3.1B-
C), tensile mechanical properties (Figure 3.2), and orthogonal control of biomolecular presentation and CG
membrane stiffness (Figure 3.3), followed by Tukey’s post-hoc test. Two-way ANOVA was performed on all
other data sets followed by a Tukey post-hoc test. Independent factors included crosslinking and immobi-
lized growth factor (PDGF-BB, BMP-2). Pairwise comparisons were performed as necessary. Mechanical
characterization used at least n = 7 membranes per group while cell number, metabolic activity and gene
expression experiments used n = 3 membranes per group, estimation of biomolecule immobilization as a
function of exposure time used n = 4 membranes per group, while biomolecule immobilization as a function
of EDC crosslinking used n = 10 membranes per group. Significance was set at p<0.05. Error bars are
reported as standard error of the mean unless otherwise noted.
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3.4 Results
3.4.1 Characterization of functional patterns of growth factors on CG
membranes
Both BMP-2 and PDGF-BB were successfully immobilized on CG membranes, either in discrete patterns
of stripes or squares (Figure 3.1A). Increasing the UV exposure time (+: 1 min.; ++: 5 min.) resulted in
significant (p<0.05) increase in immobilization of both PDGF-BB (Figure 3.1B) and BMP-2 (Figure 3.1C)
versus no UV exposure. Total immobilized protein within exposed areas was determined for PDGF (+: 0.03
ng/mm2; ++: 0.05 ng/mm2) and BMP-2 (++: 0.10 ng/mm2).
Further, while only one side of the CG membrane was directly exposed to UV light during photoim-
mobilization, identical biomolecular patterns were observed on both sides (Figure 3.4). Therefore for all
subsequent bioactivity assays, cells were seeded on both sides of the membranes after BP-photopatterning.
3.4.2 Mechanical properties of crosslinked CG membranes
CG membranes were crosslinked using a range of carbodiimide crosslinking intensities. Increasing the
EDC:NHS:COOH crosslinking ratio (NX: non-crosslinked; 1:1:5; 5:2:5; 5:20.7:1; 5:2:1) led to a significant
(p<0.05) increase in membrane stiffness. Here, three crosslinking chemistries (NX; 5:20.7:1; 5:2:1) were
identified that led to significant (p<0.001) differences in membrane stiffness (2.85 ± 0.22, 3.86 ± 0.14, 5.05
± 0.24 MPa) between all groups (Figure 3.2).
3.4.3 Orthogonal control of biomolecular patterning and CG membrane
stiffness
To confirm the capacity to orthogonally manipulate mechanical stiffness and immobilized biomolecules, we
assessed the coordinated changes of EDC crosslinking and BP photoimmobilization. Notably, while UV
exposure has been used to crosslink collagen biomaterials, increasing UV exposure (even to the level of
20 minutes, far beyond the maximal 5 minute exposure used for BP photoimmobilization) did not impact
EDC crosslinked membrane stiffness (Figure 3.3A). Further, increasing EDC crosslinking did not impact BP
photoimmobilization (Figure 3.3B). Together, these suggest orthogonal control of biomolecular patterning
and CG membrane stiffness for the range of stiffness and biomolecular pattern densities reported here.
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3.4.4 Cellular bioactivity and gene expression on CG membranes patterned
with PDGF
We then explored the coordinated impact of substrate stiffness (2.85, 3.86, 5.05 MPa) and immobilized
PDGF (−, +, ++) on the proliferation and metabolic activity (Figure 3.5; Figure 3.6) as well as changes in
osteogenic gene expression profile (Figure 3.7; Figure 3.12) of ASCs. Notably, ASC metabolic activity was
significantly (p<0.001) impacted by immobilized PDGF regardless of membrane stiffness (Figure 3.5A). Here
ASC showed an approximately 2-fold increase in metabolic activity by day 7 in the presence of photoim-
mobilized PDGF, but showed no response to changes in matrix stiffness. ASC proliferation showed similar
response (Figure 3.5B). Two-way ANOVA suggested significant (p<0.05) interaction between matrix stiffness
and PDGF immobilization, though comparison between all groups identified a significant (p<0.001) influence
of immobilized PDGF on ASC proliferation. The greatest increase in cell number was on moderately stiff
membranes, suggesting an optimal stiffness for cell proliferation (Figure 3.5B). Examining gene expression
profiles of the ASCs, more complex relationships between matrix stiffness and immobilized PDGF appeared
(Figure 3.7). Expression of type I collagen alpha-1 (COL1A1; Figure 3.7A) was significantly (p<0.05) down-
regulated with increasing stiffness and increasing PDGF immobilization, while alkaline phosphatase (ALP;
Figure 3.7B) was significantly (p<0.05) downregulated only with increasing PDGF immobilization. Com-
paratively, osteocalcin (OCN; Figure 3.7C) expression was significantly (p<0.001) upregulated with matrix
stiffness, but significantly (p<0.001) downregulated with increasing PDGF immobilization. However, no
interactions were observed between matrix stiffness and immobilized PDGF.
3.4.5 Cellular bioactivity and gene expression on CG membranes patterned
with BMP-2
We then examined the coordinated impact of substrate stiffness (2.85, 3.86, 5.05 MPa) and immobilized
BMP-2 (−,++) on the proliferation and metabolic activity (Figure 3.8; Figure 3.9) as well as changes in
osteogenic gene expression profile (Figure 3.10; Figure 3.13) of ASCs. The metabolic activity and total
number of ASCs was not impacted by either substrate stiffness or immobilized BMP-2, with the exception
of a significant (p<0.05) increase in ASC number with BMP-2 on the softest substrate (Figure 3.8B). In
addition, ASCs showed a significant (p<0.05) upregulation in the osteogenic marker alkaline phosphatase
(ALP) and a decrease in the adipogenic marker peroxisome proliferator-activated receptor gamma (PPARG)
with substrate stiffness, regardless of BMP-2 immobilization (Figure 3.10A).
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3.4.6 Gene expression on membranes patterned in quadrants of PDGF and
BMP-2
We subsequently examined the interaction between BMP-2 and PDGF, creating variants of CG membranes
by sequentially immobilizing half the membrane with BMP-2, rotating the membrane 90 degrees, then
photoimmobilizing PDGF to create a single substrate with all possible protein combinations in 4 quadrants
(BMP-2/PDGF, BMP-2 only, PDGF only, no factor; Figure 3.11A). Region-specific differences in collagen
1 were observed (Figure 3.11B). Confirming observations using monolithic patterns (Figure 3.7), collagen
1 expression was downregulated with photoimmobilized PDGF (Figure 3.11B). However, photoimmobilized
BMP-2 was sufficient to both increase collagen 1 expression when presented alone as well as to rescue collagen
1 expression in the presence of PDGF and BMP-2 (Figure 3.11B).
3.5 Discussion
This work describes the development of a collagen-GAG membrane platform that enables independent
manipulation of mechanical properties and biomolecule immobilization as well as spatial control over the
location of biomolecule immobilization. It has been increasingly recognized that mechanical, structural,
and biochemical cues all impact cell bioactivity This constellation of substrate properties has the potential
to act synergistically or destructively, or may differentially prime cell response to other signals, making
strategies to orthogonally control these cues an important design target. However, orchestrated control of
these properties is challenging. Many studies have focused on controlling only one property at a time, such
as PDGF to induce cell proliferation9,67–69, BMP-2 to promote a pro-osteogenic phenotype29,70,71, or the
use of IGF-124 or TGF-β 72–74 to promote a pro-tenogenic phenotype. And while some recent approaches
have begun to explore the combinatorial effects of matrix stiffness and biomolecular signals40,44,45, strategies
to incorporate spatial control over biomolecular signals remains poorly developed.
In this work we describe integration of carbodiimide crosslinking and benzophenone photolithography
methods to investigate independent and combined effects of biophysical signals (stiffness) and multiple
biomolecular cues (BMP-2, PDGF-BB) on porcine adipose derived stem cells using a model collagen-
GAG biomaterial. We have previously reported the utility of benzophenone-based biomolecule immobi-
lization60within the collagen-GAG biomaterial platform57 as well as on glass62,75–77, and have also demon-
strated that photoimmobilized biomolecules retain their activity ; however, we had not explored the potential
of BP-photolithography to facilitate orthogonal manipulation of matrix stiffness and growth factor immobi-
lization. In this study, PDGF and BMP-2 were chosen as model growth factors due to their known potential
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to impact cell proliferation6,9 and osteogenesis29,45,53, respectively. While tracking proliferation and gene
expression profiles of porcine adipose derived stem cells is well defined63, the relative impact of PDGF and
BMP-2 on these processes remained unknown.
We first demonstrated that both factors could be covalently immobilized to the CG membrane in defined
patterns, and that these patterns extended through the depth of the membranes (Figure 3.1, Figure 3.4).
We subsequently demonstrated the utility of a combined photolithography-carbodiimide crosslinking strat-
egy to orthogonally manipulate matrix stiffness and biomolecule immobilization. Similar to previous ob-
servations54,55,78, increasing EDC:NHS:COOH ratios increased collagen-GAG stiffness. Here we identified
3 crosslinking treatments (Figure 3.2) and created substrates with significantly different elastic moduli.
Crosslinking treatments were chosen so that all substrate were kept in a closely related range of stiffness
(2.85–5 MPa). Importantly, UV exposure during BP photolithography did not significantly impact me-
chanical properties of the membranes and EDC crosslinking did not impact later surface bioconjugation
(Figure 3.3). Previously, we demonstrated that BP photoimmobilization does not impact the crystallinity or
structural properties of the collagen fibers within the CG biomaterial57. Together, these results suggest that
sequential use of EDC-crosslinking and BP-photolithography provides a platform to orthogonally manipulate
the elastic modulus and presence of immobilized biomolecules within a model CG-biomaterial.
We subsequently investigated the individual and coordinated impact of matrix stiffness and biomolecule
(PDGF, BMP-2) attachment on adipose-derived mesenchymal stem cell bioactivity (Figures 4–7). While
many of these results are consistent with previous findings in the literature that investigated the monolithic
impact of PDGF3,6,9,79, BMP-229,30, or matrix stiffness38,40, results reported here serve as an important
proof-of-principle of a coordinated approach to examine the intersection between mechanical and biomolec-
ular signals. We observed significantly increased metabolic activity and cell proliferation on substrates with
low and high doses of immobilized PDGF as compared to controls (Figure 3.5). We also found that matrix
stiffness contributed to cell proliferation, which peaked at intermediate substrate stiffness at the highest dose
of PDGF. Matrix stiffness has previously been shown to increase growth-factor-dependent Erk activation
through focal adhesion assembly80, providing an explanation for our observed differential response in PDGF-
induced proliferation. The facile identification of a combination of PDGF density and substrate stiffness to
increase proliferation highlights the potential of our approach. Similar to our previous observations of exam-
ining tenocyte bioactivity in response to PDGF supplementation6, there appeared to be a tradeoff between
cell proliferation and phenotype with PDGF supplementation (Figure 3.7). While COL1A1, ALP, and OCN
expression were all upregulated with increasing stiffness, this effect was lost with addition of the pro-growth
signal, PDGF (Figure 3.7). We subsequently examined the effects of BMP-2 immobilization and matrix stiff-
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ness on ASC bioactivity and gene expression. To simplify analysis, we chose to examine the presence/absence
of photoimmobilized BMP-2 rather than dose-dependent results. Consistent with previous findings in the
literature79,81, we found cell bioactivity was not correlated with BMP-2, and additionally noted a lack of
coordinated interaction between BMP-2 and substrate stiffness (Figure 3.8). Although BMP-2 is a known
pro-osteogenic factor, we observed that photoimmobilized BMP-2 had little effect on lineage-specific gene
expression. Instead, stiffness had a major effect on ASCs which exhibited increasing pro-osteogenic ALP ex-
pression and decreasing pro-adipogenic PPARG expression with increasing substrate stiffness (Figure 3.10).
The impact of matrix stiffness on changes in pro-osteogenic vs. pro-adipogenic gene expression profiles is
consistent with previous observations in the literature82. While initially surprising, the lack of an effect of
BMP-2 on pro-osteogenic gene expression profiles suggest that over the range of stiffness and BMP-2 density
tested here, ASC response is dominated by matrix mechanical properties. Ongoing efforts are exploring a
wider range of matrix stiffness and immobilized BMP-2 densities. Further, as BP-photoimmobilization has
been shown to be effective within fully-3D CG scaffolds, future efforts will likely explore the coordinated
impact of matrix stiffness, pore size, and BMP-2 immobilization in the context of regenerative medicine
approaches for critical size bone defects.
To demonstrate the greater potential for integrating BP photolithography with the CG biomaterial plat-
form, we lastly examined spatially-defined interactions between PDGF and BMP-2 (Figure 3.11). Such an
effort is a demonstration of principle for ongoing efforts exploring a wider range of pattern densities and
their resultant impact on ASC response. Here, we examine the impact of the highest immobilization density
of both PDGF and BMP-2 on the substrate with the greatest stiffness. No significant difference in metabolic
activity or cell number was observed after 7 days (data not shown); however, expression of COL1A1 was
strongly increased with the presence of BMP-2 alone or in combination with PDGF (Figure 3.11). Substrates
containing PDGF alone, or no immobilized growth factors, showed marked downregulation of COL1A1, con-
sistent with observations for monolithic PDGF immobilization (Figure 3.7). Given the observed interactions
between matrix stiffness and biomolecule immobilization, future efforts will leverage this approach to explore
a wider range of combinatorial environments. Further, given recent observations that matrix stiffness can
impact MSC receptivity to biomolecular signals44, the system described here may offer unique potential
to rapidly assess signal transduction and cell response for a range of matrix environments across a sin-
gle substrate via immunofluorescence-based assays. Here, efficient identification of combinations of matrix
mechanical and biomolecular signals able to support enhanced ASC bioactivity in the absence of media
supplementation provides the foundation for developing instructive biomaterials containing selective alter-
ations to mechanical and compositional properties to enhance multi-lineage ASC specification in a spatially
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selective manner.
3.6 Conclusions
This work establishes the ability to separate fabrication and biomolecule patterning via a molecularly-
general biomolecule photoimmobilization method using a CG biomaterial. We demonstrated sequential use
of carbodiimide crosslinking and benzophenone photoimmobilization chemistries to independently control
immobilization of multiple biomolecular species (PDGF, BMP-2) as well as the mechanical properties of a
model CG substrate. Notably, this approach allows us to identify the coordinated impact of mechanical and
biochemical cues on ASC metabolic activity, proliferation, and gene expression profile. Overall, our results
highlight how the bioactivity and lineage commitment of adipose stem cells depend on a variety of cues whose
optimal combinations are difficult to predict. The approach described here may prove particularly valuable
for high throughput screening of biomaterials to identify environments supportive of a range of stem cell
phenotypes. Given the certain complexity of the chemical and mechanical environments that determine stem
cell fate and lineage commitment, this capability to independently control both classes of cue presentation
should enable more facile engineering of customized scaffold materials applicable to a wide range of tissue
engineering goals. These efforts are informing ongoing work in our lab to enhance the regenerative potential
of spatially-gradated CG scaffolds for regenerative repair of orthopedic insertions such as the osteotendinous
junction.
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3.7 Figures
Figure 3.1: (A) Representative image of photoimmobilized PDGF (stripe) and BMP-2 (square) on CG
membranes. Scale bar: 500 µm. (B) Immobilization of PDGF-BB as a function of UV exposure time (1, 5
min) normalized versus non-irradiated control. (C) Immobilization of BMP-2 as a function of UV exposure
time (1, 5 min) normalized versus non-irradiated control. *: significant increase versus non-irradiated control.
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Figure 3.2: Elastic modulus of crosslinked CG membranes as a function of EDC:NHS crosslinking intensity.
*: significant difference between groups.
Figure 3.3: Orthogonal control of biomolecular patterning and CG membrane stiffness. (A) Elastic modulus
of CG membranes as a function of UV exposure. (B) Mean fluorescence intensity of photoimmobilized PDGF
(UV: 5 min.) as a function of EDC crosslinking intensity. Results reported as mean ± standard deviation.
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Figure 3.4: Representative images of both sides of a single CG membrane. PDGF was immobilized via UV
exposure on only one side of the membrane. However, stripes of immobilized PDGF are visible on both the
(A) front and (B) back of the membrane. Scale bar: 500 µm.
46
Figure 3.5: (A) ASC metabolic bioactivity and (B) overall cell number at day 7 on CG membranes as
a function of substrate stiffness and photoimmobilized PDGF. †: significant increase compared to non-
PDGF functionalized substrate of identical stiffness. Individual comparisons (substrate stiffness, PDGF
immobilization) between all groups are shown in Figure 3.6.
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Figure 3.6: (A) ASC metabolic bioactivity at a defined PDGF immobilization (−, +, ++) with increasing
stiffness and (B) at a defined substrate stiffness (2.85 MPa, 3.86 MPa, 5.05 MPa) with increasing PDGF
immobilization. (C) ASC cell number at a defined PDGF immobilization (−, +, ++) with increasing
stiffness and (D) at a defined substrate stiffness (2.85 MPa, 3.86 MPa, 5.05 MPa) with increasing PDGF
immobilization. *: significant difference between groups.
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Figure 3.7: Gene expression profiles of (A) collagen 1 (COL1A1), (B) alkaline phosphatase (ALP), and
(C) osteocalcin (OCN) for ASCs cultured on CG substrates as a function of stiffness and photoimmobilized
PDGF. *: significant increase compared to softest substrate with identical immobilized protein concentra-
tion. †: significant down-regulation compared to non-PDGF functionalized substrate of identical stiffness.
Individual comparisons (substrate stiffness, PDGF immobilization) between all groups are shown in Fig-
ure 3.12.
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Figure 3.8: (A) ASC metabolic bioactivity and (B) overall cell number at day 7 on CG membranes as a
function of substrate stiffness and photoimmobilized BMP-2. †: significant difference compared to substrate
of equal stiffness but without BMP-2. Individual comparisons (substrate stiffness, BMP-2 immobilization)
between all groups are shown in Figure 3.9.
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Figure 3.9: (A) ASC metabolic bioactivity at a defined BMP-2 immobilization (−, ++) with increasing
stiffness and (B) at a defined substrate stiffness (2.85 MPa, 3.86 MPa, 5.05 MPa) with increasing BMP-2
immobilization. (C) ASC cell number at a defined BMP-2 immobilization (−, ++) with increasing stiffness
and (D) at a defined substrate stiffness (2.85 MPa, 3.86 MPa, 5.05 MPa) with increasing BMP-2 immobi-
lization. *: significant difference between groups.
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Figure 3.10: Gene expression profiles of ASCs cultured on CG substrates as a function of stiffness and pho-
toimmobilized BMP-2. (A) Alkaline phosphatase (ALP) expression is upregulated with substrate stiffness. *:
significant decrease relative to stiffest membrane with no protein. (B) Adipogenic peroxisome proliferator-
activated receptor gamma (PPARG) expression decreases with increasing substrate stiffness. Individual
comparisons (substrate stiffness, BMP-2 immobilization) between all groups are shown in Figure 3.13.
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Figure 3.11: Schematic of 4-quadrant overlapping pattern of PDGF and BMP-2 generated on CG membranes.
(B) Gene expression levels of collagen 1 (COL1A1) normalized versus ASCs on control substrates (–/–).
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Figure 3.12: Gene expression profiles of (A, B) collagen 1 (COL1A1), (C, D) alkaline phosphatase (ALP), and
(E, F) osteocalcin (OCN) for ASCs cultured on CG substrates at (A, C, E) a defined PDGF immobilization
(−, +, ++) with increasing stiffness and (B, D, F) at a defined substrate stiffness (2.85 MPa, 3.86 MPa,
5.05 MPa) with increasing PDGF immobilization. *: significant difference between groups.
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Figure 3.13: Gene expression profiles of (A, B) alkaline phosphatase (ALP) and (C, D) peroxisome
proliferator-activated receptor gamma (PPARG) for ASCs cultured on CG substrates at (A, C) a defined
BMP-2 immobilization (−, ++) with increasing stiffness and (B, D) at a defined substrate stiffness (2.85
MPa, 3.86 MPa, 5.05 MPa) with increasing BMP-2 immobilization. *: significant difference between groups.
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3.8 Tables
Table 3.1: Primer sequences used for qPCR.63
Name Forward Primer (5’-3’) Reverse Primer (5’-3’)
COL1A1 AGAAGAAGACATCCCACCAGTCA CCGTTGTCGCAGACACAGAT
OCN GAGGGAGGTGTGTGAGCTCAA GGCTGCGAGGTCTAGGCTATG
ALP CCCTTCACTGCCATCCTGTAC GGTAGTTGTCGTGCGCATAGTC
PPARG GAGCCCAAGTTCGAGTTTGC GGCGGTCTCCACTGAGAATAAT
GAPDH GTCAAGCTCATTTCCTCGTACGA CTCTTACTCCTTGGAGGCCA
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Chapter 4
A Tunable, Photoreactive Hydrogel
System to Probe Synergies Between
Mechanical and Biomolecular Cues on
Adipose-Derived Mesenchymal Stem
Cell Differentiation
We acknowledge funding for this work from the National Science Foundation Division of Material Research
under award 1105300. Porcine adipose-derived stem cells were a gift from Prof. M. Wheeler (UIUC) with
assistance from A. Maki. We thank C. Herman for synthesis of the benzophenone methacrylamide monomer.
We thank Prof. H. Kong (UIUC) for use of the mechanical testing system. We also acknowledge A. Alsop
for helpful discussions.
4.1 Abstract
Here we describe the incorporation of the photoreactive molecule benzophenone into polyacrylamide hydro-
gels, allowing for orthogonal control over spatial incorporation of biomolecules and selective modulation of
matrix stiffness. We examine differentiation of adipose-derived stem cells (ASCs) cultured on matrices whose
elastic moduli are tuned to ∼5kPa, ∼14kPa, and ∼37kPa combined with an immobilized growth factor, bone
morphogenic protein 2 (BMP-2). We observe that BMP-2 has the most pronounced effect at the interme-
diate stiffness, while the lowest and highest stiffness hydrogels are directed by elasticity alone. Together,
this approach describes a facile platform for fundamental studies of cell fate decisions in the context of both
mechanical and biochemical cues, and may lead to improved insight and effectiveness of stem cell therapies.
4.2 Introduction
Stem cell therapy holds great promise for the treatment of injuries and diseases, including many applications
in tissue regeneration.1 In order to fully utilize stem cells in such applications, biomaterials that facilitate
study over the individual and combined effects of multiple external parameters on cell fate and function is
necessary.2,3 In the human body, cells receive and integrate a complex and diverse series of stimuli presented
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by the microenvironment. The extracellular matrix mediates the presentation of both adhesive proteins and
growth factors.4 Recent studies have also shown that mechanical stimuli exert a profound effect on stem cell
renewal and differentiation.5–8 Understanding the combined effects of the matrix environment on cell fate
is of particular importance for the field of regenerative medicine, as injury may lead to changes in matrix
biomolecular and mechanical properties; for example, fibrotic scarring and subsequent local stiffening is often
observed in response to tissue damage.9
Physical and chemical factors not only play key individual roles, but also act cooperatively to orchestrate
cell behavior. Crosstalk between integrin and growth factor signaling pathways is known to direct cell
migration, proliferation, and differentiation.10 McBeath and coworkers showed that mechanotransduction
via RhoA/ROCK-mediated contractility controls stem cell differentiation into adipocytes or osteoblasts.11
Furthermore, the role of BMP/Smad signaling in studies by Du et. al suggested that stiffness-mediated
activation of β1 integrin and subsequent integrin-mediated internalization of BMP-2 receptor accounts for
inhibited osteogenic differentiation on soft substrates.12 Activation of both RhoA/ROCK and FAK signaling
mediated by differential integrin expression on stiffer substrates was also shown to regulate osteogenesis via
the ERK1/2 pathway.13 Such intersecting network signaling has been implicated in priming growth factor
signaling on stiffer substrates.14 However, despite intensive research efforts, much remains to be elucidated
about the complex interplay of physical and chemical signals as combinations of these factors can have
unpredictable or unintended consequences.15 For example, we previously reported a tradeoff between stem
cell growth and differentiation that was remedied by combined presentation of proliferative and osteogenic
factors,16 highlighting the fact that new approaches are needed to create defined biomaterials to orthogonally
modulate both the mechanical and biomolecular microenvironment.
Polymer hydrogels have been used extensively as substrates for fundamental studies of cell-material
interactions owing to their inertness, high water content, permeability, synthetic tenability, and tissue-
like elasticity.17 Although hydrogels consist mostly of water, incorporation of biochemical cues has been a
common approach to elucidate fundamental aspects of cellular function.18 A range of techniques have been
applied to modify hydrogels with bioactive moieties, including covalent conjugation (e.g. thiol,19 azide20)
or non-covalent affinity interactions (e.g. heparin,21 biotin22), but these methods often lack the capacity to
control the spatial organization of these cues. Further, they often require exogenous labeling of bioactive
moieties or the presence of binding partners.23,24 Moreover, soft nonplanar substrates are not typically
amenable to flow or contact-based patterning approaches and often do not allow for modular control over
the presentation of multiple factors.25
Our group, and others, have recently investigated the use of direct immobilization of biomolecules using
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benzophenone photolithography, a simple technique that provides control over the amount and location of
biomolecule immobilization regardless of surface topology.26–31 Here, BP molecules are covalently incorpo-
rated into a biomaterial. Subsequent UV exposure creates a transient benzophenone diradical that either
abstracts a hydrogen from a nearby C-H bond available on a solution-phase biomolecule and recombines—
resulting in a covalent C-C bond—or relaxes to the ground state from which it can be re-excited.32 Increas-
ingly complex biomolecule patterning would otherwise require multiple orthogonal chemical modifications,
but the broad C-H bond reactivity of benzophenone allows immobilization of multiple molecules without the
need for (bio)chemical modification. Importantly, the benzophenone-based spatial patterning strategy al-
lows for the post-synthetic modification of various biomaterial constructs in a way that does not perturb the
intrinsic mechanical properties.16 This is in contrast to alternative strategies that either require the incor-
poration of biomolecular cues during the creation of the scaffold itself (e.g. during hydrogel polymerization)
or covalent crosslinking chemistries that often lead to substrate stiffening.33
In order to derive meaningful information from cellular interactions with the surrounding environment,
it is highly desirable to control both the physical and biomolecular properties of a biomaterial. Unlike ECM-
derived materials, synthetic hydrogels offer increased control over chemical composition and modifiable
mechanical properties more similar to native tissue. Here, we apply a simple photolithographic method
to create matrices from polyacrylamide, a non-fouling polymer that will allow specific control of only the
chosen molecules on the surface. With the additional spatial control provided by using light as a reagent, the
integration of the benzophenone-based derivatization approach offers significant opportunities for improving
the efficiency and biomimetic complexity of screening cell-substrate interactions. As a first demonstration, we
explore combining these cues on a porous two-dimensional substrate; however, this strategy could be easily
translated to three-dimensional architectures that more closely resemble the ECM structure. To determine
and decouple the collective roles that biochemical and physical cues play in modulating the differentiation of
mesenchymal stem cells, we report the application of BP photolithography to study the effect of mechanical
properties in the presence and absence of BMP-2, a potent osteogenic factor.34
4.3 Materials and methods
All general laboratory supplies were purchased from Fisher Scientific and reagents purchased from Sigma-
Aldrich unless otherwise noted.
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4.3.1 Synthesis of N-[3-[(4-benzoylphenyl) formamido]propyl] methacrylamide
(BPMAC)
The synthesis of benzophenone methacrylamide monomer BPMAC was adapted from previously described
conditions,35 and shown in Figure 4.1. Briefly, 4-benzoylbenzoic acid (BBA) was reacted with N-(3-
aminopropyl)methacrylamide (APMA) in the presence of 4-(dimethylamino)pyridine (DMAP) and (1-ethyl-
3-(3-dimethylaminopropyl)carbodiimide (EDC) in dimethylformamide (DMF). BBA (1.3 mmol) was mixed
with the other reactants in DMF at a molar ratio of 1.2:1.2:1:1 EDC:DMAP:BP:APMA and stirred overnight
at room temperature. The solution was poured into 90 mL CH2Cl2 and washed five times with H2O (30
mL), followed by 5 washes with 50 mM NH4C2H3O2, (30 mL, pH 4.5). The organic phase was dried over
Mg2SO4 and solvent was removed under vacuum. The synthesis yield was 75% and the white solid was
confirmed to be consistent with the literature by 1H NMR and positive ion ESI MS. The pure material was
stored in 100 mM aliquots in DMSO at −20 °C.
4.3.2 Fabrication of hydrogels
Polyacrylamide gels were fabricated from monomer solutions containing acrylamide and bisacrylamide (GE
Life Sciences) in ratios of 10:0.3, 10:0.1, or 10:0.03 acrylamide:bis-acrylamide (%w/v) in pH 7.4 phosphate
buffered saline (PBS, Corning). When indicated, benzophenone methacrylamide was added from 100mM
stock solution in DMSO at a 1:100 volume ratio. These monomer solutions were filtered using 0.2 ?m
filters and degassed under vacuum immediately prior to use. Free radical polymerization was initiated
by adding 1:10 total volume ammonium persulfate solution (8mg/mL, Bio-Rad) and 1:100 total volume
tetramethylethylenediamine (Bio-Rad) to gel solutions. Gels were cast between two glass plates treated
with Repel-Silane (GE Life Sciences) separated by a 1 mm spacer. After complete polymerization (∼1 h),
gels were removed from the plates, swollen in PBS overnight, and punched into 8 mm discs using a dermal
biopsy punch (Integra-Miltex). Gels were then stored protected from light in PBS at 5 °C until use.
4.3.3 Biomolecule photoimmobilization and visualization
Prior to photopatterning, hydrogels were first incubated with the protein of interest; bone morphogenetic
protein 2 (BMP-2, R&D Systems) and/or fibronectin (R&D Systems) at 5 µg/mL in PBS for 1 hour. Gel
disks were then exposed to UV light (351-364 nm) through a photomask using a beam expanded and intensity
homogenized (pi-shaper, Molecular Technologies, Berlin, Germany) Argon ion laser (Coherent Innova 90-4,
Laser Innovations). For gradient immobilization, a translation stage (ThorLabs) was programmed to move a
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shutter so as to gradually reveal the substrate over a defined time period during illumination. For substrates
containing both fibronectin and BMP-2, the proteins were uniformly and sequentially deposited one at a
time with PBS rinsing in between. Hydrogels for cell culture experiments were rinsed for 1 hour in PBS and
stored at 5 °C until use. Hydrogels used to visualize the immobilized biomolecule were rinsed in 0.2% pluronic
F-127 in PBS and blocked in 1% BSA-PBS for 1 hour each before staining with primary rabbit anti-BMP-
2 antibody (AbCam) and secondary goat anti-rabbit IgG AlexaFluor-647 antibody conjugate (Invitrogen)
in 1% BSA-PBS overnight. Samples were rinsed in PBS before being imaged using a microarray scanner
(Molecular Devices).
4.3.4 Mechanical characterization
Substrate stiffness was evaluated by measuring the elastic modulus of 8 mm hydrogel disks following incu-
bation in PBS overnight at room temperature. Samples were tested by uniaxial compression at a rate of 1
mm/min using a mechanical testing system (Insight, MTS Systems) and data collected and analyzed using
TestWorks software. The elastic modulus was calculated by fitting the linear regime (i.e. the first 10%) of
the stress-strain curve.
4.3.5 Adipose-derived mesenchymal stem cell culture
Adipose-derived mesenchymal stem cells (ASCs) were harvested from porcine donors as previously de-
scribed and preserved in liquid phase nitrogen.36 ASCs were cultured in standard flasks at 5,000 -10,000
cells/cm2 with Dulbecco’s High Glucose Modified Eagles Medium (DMEM) supplemented with Penicillin-
Streptomycin, amphotericin B, and 10% fetal bovine serum (Cell Media Facility, UIUC School of Chemical
Sciences). Prior to culture experiments, hydrogel specimens (post-functionalization) were sterilized with
UV, placed in low-attachment 24-well plates (Corning) and incubated in serum-free DMEM at 37 °C for at
least 30 minutes prior to cell seeding. Cells were collected using trypsin-EDTA and resuspended in complete
DMEM with serum at a concentration of ∼4,500 cells per 15 µL. Substrates were seeded at low density to
reduce cell-cell interactions by placing 15 µL of cells onto each specimen. Cells were allowed to attach for 1
hour, followed by addition of complete DMEM. Media, which was changed every 3-4 days.
4.3.6 Metabolic activity
Following incubation with alamarBlue reagent (Invitrogen) for 2 hours, resorufin fluorescence was measured
using a fluorescence microplate reader (Tecan). Relative cell metabolic activity was determined and reported
as a percentage of the control (without BP, protein, or UV exposure).37
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4.3.7 Cell staining and fluorescence microscopy
Cell-laden hydrogels were rinsed in PBS and then fixed in 10% neutral buffered formalin for 30 minutes
followed by rinsing three times in PBS. For fluorescence staining, samples were permeabilized in a solution
of 1% Triton X-100 in PBS for 30 minutes, blocked in a solution of 1% bovine serum albumin in PBS for 30
minutes, and then incubated with rhodamine-phalloidin (diluted 1:500) and/or DAPI (diluted 1:1000) for
30 minutes. Samples were rinsed and stored in PBS at 5 °C. For Oil Red O staining, a working solution was
freshly prepared from a 0.3% (w/v) solution of Oil Red O in isopropanol by diluting 3 parts of the stock
solution to 2 parts deionized water and filtering through filter paper. Samples were incubated twice with
60% isopropanol for 5 minutes, and then incubated in the Oil Red O solution for 5 minutes before rinsing
thoroughly with PBS. All fluorescence and brightfield cell images were taken using an EVOS microscope
(Advanced Microscopy Group).
4.3.8 Alkaline phosphatase (ALP) activity
Alkaline phosphatase activity was measured on day 7 using p-nitrophenyl phosphate (pNPP, AbCam), a
colorimetric substrate that turns yellow when dephosphorylated by the enzyme. Cell culture medium was
collected, incubated with pNPP solution, and the resulting absorbance read at 405 nm. Activity in glycine
units was determined by comparison with a standard curve. To ensure activity differences were not due to
larger numbers of cells, the cells on hydrogels were lysed in RIPA buffer (Invitrogen), diluted in Tris-EDTA
buffer, and measured for consistent DNA content using Hoechst 33342 via fluorescence measurement using
a microplate reader (Tecan).
4.3.9 Real-time quantitative reverse transcriptase PCR (qPCR)
Quantification of lineage-specific RNA targets was performed via real-time quantitative reverse transcriptase
PCR (qPCR). Samples were rinsed in PBS and the RNA isolated using an RNeasy mini kit (Qiagen). RNA
was converted to cDNA in a 20 µL volume using QuantiTect reverse transcription kit according to the
manufacturer’s instructions. PCR primers (see Table 4.1) for alkaline phosphatase (ALP), type 1 collagen
alpha-1 (COL1A1), osteocalcin (OCN), peroxisome proliferator-activated receptor gamma (PPARG), and
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) were selected from those previously validated in the
literature.36 qPCR was performed using a QuantiTect SYBR Green RT-PCR kit (Qiagen) according to the
manufacturer’s instructions on a 7900HT Fast Real-Time PCR system (Applied Biosystems) and the cycle
threshold data collected using SDS software. Data was converted to relative expression using the ∆∆CT
method with GAPDH as a housekeeping gene and log transformed for graphical representation.
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4.3.10 Statistical analysis
All data are presented as mean (n=3) ± standard deviation unless otherwise specified. Statistical significance
was determined using t-test for pairwise comparisons or ANOVA followed by Tukey’s Multiple Comparison
Test or uncorrected Fisher’s LSD for groups of three or more.
4.4 Results and discussion
The extracellular matrix is a network presenting immobilized growth factors and physical cues that direct
cell behavior. Exciting progress has been made in deciphering the complexity of the ECM; however, much of
this work has focused individually on a single class of cell stimuli: microstructure, mechanics, or presented
biomolecules. However, the multifactorial studies probing synergistic effects across these different classes have
been relatively underexplored. In this work, we sought to systematically examine mesenchymal stem cell
fate decisions in response to the osteogenic factor bone morphogenic protein 2 (BMP-2) while simultaneously
varying the hydrogel stiffness.
4.4.1 Hydrogel fabrication and characterization: Independent control over
biomolecular presentation and mechanical properties
We have previously reported the use of benzophenone photolithography in immobilizing bioactive molecules
on planar and non-planar glass and collagen substrates.16,28,31,38,39 Here we incorporated the benzophenone
moiety into a crosslinked polyacrylamide hydrogel system to enable presentation of biomolecules in a spatially
defined manner as shown in Figure 4.2a. This attachment strategy allowed us to selectively incorporate
fibronectin for cell adhesion as well as BMP-2, an osteoinductive factor, on the surface of polyacrylamide
hydrogels. Here we were able to control both the location of protein immobilization via a photomask to
define an area of illumination, while creating gradients in local BMP-2 dose via the use of an opaque shutter
mounted to a translation stage (Figure 4.2b). We quantified the increase in biomolecule immobilization with
increasing UV exposure time (Figure 4.2c, p ≤ 0.001), and observed negligible protein attachment to a UV
and BMP-2 exposed control hydrogel that lacked benzophenone (−BP).
A major benefit of the hydrogel system is that in addition to tailoring local biomolecule presentation, the
elastic modulus of the substrates can also be separately controlled by varying the amount of bisacrylamide
crosslinker incorporated into the hydrogel. We created hydrogels of low, medium, and high bulk stiffness
(∼5kPa, ∼14kPa, and ∼37kPa) corresponding to reported moduli of adipose, muscle, and bone tissue.40 The
ratios of 10:0.3, 10:0.1, and 10:0.03 acrylamide:bis-acrylamide (%w/v) were found to produce these desired
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substrate stiffnesses as shown in Figure 4.3a and Figure 4.4. The modulus increased significantly (p ≤ 0.001)
with increasing amounts of crosslinker, consistent with previous reports.41 Importantly, we found that neither
the incorporation of benzophenone nor UV exposure significantly affected the mechanical properties of the
hydrogels. This is significant because it demonstrates the ability of this approach to modulate stiffness
independent of the presentation of biomolecular cues.
4.4.2 Cell viability on benzophenone hydrogels
We confirmed that cell viability on BP-containing substrates was not adversely affected compared to sub-
strates with no growth factor (BMP-2) or no BP. We observed no significant difference in the metabolic
activity of ASCs on each substrate at day 1 or day 7 in culture (Figure 4.3b). Microscopic imaging of cell
morphology of ASCs cultured on BP-hydrogels confirmed healthy spreading and proliferation, as visualized
by nuclear and actin cytoskeleton staining in Figure 4.3c.
4.4.3 Influence of stiffness on ASC differentiation
In the absence of adhesion ligands, non-fouling polyacrylamide hydrogels do not support cell adhesion. There-
fore, in order to determine the effect of stiffness alone on cell differentiation, adipose-derived mesenchymal
stem cells were seeded onto substrates of low, medium, and high elastic moduli onto which fibronectin was
photoimmobilized to promote cell adhesion. Gene expression analysis after 7 days focused on a combination
of bone-specific (ALP, COL1A1, and OCN) and a fat-specific marker (PPARG) as shown in Figure 4.5a.
We observed that the highest stiffness substrates led to significantly elevated expression of ALP and OCN
(p ≤ 0.05), and COL1A1 showed a significant linear trend (p ≤ 0.05) in expression with increasing stiffness.
Conversely, the bone-specific PPARG showed a significant decrease in expression with increasing substrate
stiffness (p ≤ 0.05). These results suggest that cells cultured on ∼37kPa substrates are inclined towards an
osteogenic phenotype and a reduction in adipose character, consistent with reports in the literature.40
This trend towards increasing osteogenic character with increasing substrate stiffness was further con-
firmed through assays for functional alkaline phosphatase activity, which signifies bone-like tissue formation.
After 7 days of culture, the stiffest substrates showed the highest ALP activity, followed by medium and
then low stiffness substrates (Figure 4.5b, p ≤ 0.05).
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4.4.4 Combined influence of stiffness and immobilized BMP-2 on ASC
differentiation
To probe the combined effects of mechanical and biomolecular cues, we immobilized BMP-2 on substrates
of varying stiffness and utilized qPCR and ALP activity assays to determine relative osteogenic versus
adipogenic lineage character. After 7 days in culture, medium stiffness substrates showed the greatest fold
expression changes compared control substrates in expression of lineage-specific marker genes (Figure 4.6a).
Expression levels of ALP and OCN were ∼11 and ∼7 fold higher, respectively, in the medium stiffness
condition versus control. The magnitude of fold change was significantly higher on medium substrates as
compared to low and high stiffness conditions (p ≤ 0.05) and adipogenic marker PPARG was significantly
decreased (p ≤ 0.05). In the stiffest substrates, we observed less pronounced upregulation of ALP, OCN,
and COL1A1 compared to the control lacking BMP-2, likely because the expression was already substantial
in the baseline condition. Furthermore, the lowest stiffness substrates showed little change compared to
the non-functionalized control. Interestingly, these results suggest that synergistic combinations of stiffness
and BMP-2 have the power to optimize specific cell differentiation outcomes. Given the interdependence of
mechanical and biochemical properties to mediate cell behavior, this platform could be a valuable tool for
control of key stem cell niche attributes.
Alkaline phosphatase activity was measured as a function of stiffness and BMP-2 immobilization, sup-
porting the trend observed in the gene expression studies. Similar to the ALP results discussed above, ALP
activity tends on increase with stiffness (Figure 4.6b). Compared to substrates without immobilized growth
factor, medium stiffness substrates showed the greatest relative increase in ALP activity with the addition of
BMP-2, as shown in Figure 4.6c. An increase in ALP activity was also observed for the high stiffness group;
however, the relative increase due to the addition of BMP-2 was slightly less in magnitude. Conversely, low
stiffness substrates showed a considerably smaller increase in ALP activity with BMP-2 supplementation,
which was significantly lower than medium or high stiffness groups (p ≤ 0.05).
As a final method of probing the combined mechanical and biomolecular effects within this hydrogel
system, we examined accumulation of the lipid dye Oil Red O as a marker of adipogenesis (Figure 4.7; black
arrowheads indicate positive Oil Red O staining; white arrowheads indicate cells negative for Oil Red O
staining). Consistent with gene expression and ALP activity assays, Oil Red O staining revealed significant
lipid droplet staining in cells cultured on soft substrates regardless of BMP-2 supplementation. Conversely,
the stiffest substrates appeared to have negligible Oil Red O staining with or without BMP-2, consistent
with the observation that cells on stiff membranes undergo osteogenic differentiation without the need for
growth factor supplementation. However, the medium stiffness substrates showed pronounced decreases in
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Oil Red O staining in the presence of the BMP-2, compared to non-functionalized substrates.
Taken together, these results show that cells cultured on substrates having particular stiffness are poised
to be extra responsive to the presence of immobilized biomolecule cues, suggesting that synergistic environ-
mental factors work together to optimize specific cell differentiation outcomes. In this case it is particularly
interesting that an intermediate stiffness between that of native fat and bone tissue is the most influenced
by biomolecular cues.42 In considering how tissues develop from the earliest stages where mechanical envi-
ronments are not fully established, a more heightened responsiveness to biomolecular cues might serve as a
mechanism for eliciting greater local control over cell differentiation, proliferation, and lineage commitment.
Additionally, most reports in the literature focus on efforts to drive bone-derived mesenchymal stem cell
differentiation. Notably, our findings show that adipose-derived stem cells maintain flexibility to differen-
tiate towards osteogenic or adipogenic lineage especially at intermediate stiffnesses, in the same fashion as
bone-derived cells. These results suggest strongly the need for approaches to tease apart the effect of me-
chanical, biomolecular, and microstructural guidance cues on cell fate in order to continue to shed light on
the complex synergies that underlie tissue development and regeneration. Versatile biomaterials platforms,
such as the phototunable hydrogel system described here that offer independent control over multiple classes
of cues, will play a significant role in future efforts to elucidate multifactorial control elements that regulate
the stem cell niche.
4.5 Conclusions
In this work, we have demonstrated the utility of benzophenone-containing hydrogels as a tunable platform
for screening the combined effects of local physical and chemical cues on adipose stem cell fate. Integrating
benzophenone methacrylamide into hydrogels of varying crosslinking density allowed us to tune mechanical
and biochemical properties independent of one another. This photoreactive hydrogel provides a facile strategy
for fabricating patterned and gradient designs into a hydrogel network without the need for biomolecule
labeling. We found that increasing hydrogel stiffness alone induced an osteogenic phenotype, but lineage
commitment was amplified particularly at moderate stiffness by the addition of BMP-2. This study shows
the potential of orthogonally tunable biomaterials to elucidate cell fate decisions in a combinatorial manner
and represents an important step towards building in the complexity of the native extracellular matrix.
Improving our understanding of these stimuli may lead to the development of more sophisticated materials
for regenerative medicine.
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4.6 Figures
Figure 4.1: Synthesis of benzophenone methacrylamide monomer.
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Figure 4.2: Biomolecule immobilization and characterization. (A) Schematic demonstrating the process to
introduce and utilize photoreactive monomer in polyacrylamide hydrogels to create biomolecular patterns
and gradients. (B) Fluorescence micrograph and quantitation of hydrogel substrate presenting immobilized
gradient of BMP2 in a vertical stripe pattern visualized using AlexaFluor647-labeled anti-BMP-2 (red, scale
bar=500 µm). (C) Photochemical immobilization of BMP-2 corresponds to UV exposure time. Data are
mean ± SD, n=3, (*) significantly different than all other exposure time groups, p ≤ 0.001; (#) control is
significantly different than all other exposure time groups, p ≤ 0.05.
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Figure 4.3: Mechanical characterization and biocompatibility of polyacrylamide hydrogel substrates. (A)
Elastic modulus of hydrogel discs with and without benzophenone monomer; before and after UV exposure.
Stiffness is varied through monomer:crosslinker ratio — Low, 10:0.03; Medium; 10:0.1; High, 10:0.3 (%w/v).
Data are mean ± SD, n=3, ns=no statistical significance (p >0.05); (†) significantly greater than Low group,
p ≤ 0.01; (‡) significantly greater than Low and Medium groups, p ≤ 0.001; (§) significantly greater than Low
group, p ≤ 0.001. (B) Metabolic activity is not affected by the presence of benzophenone methacrylamide
(BP), BMP-2 or UV light. Data are mean ± SD, n=4, ns=no statistical significance (p >0.05). (C)
Fluorescence micrograph of ASCs cultured on benzophenone-containing hydrogels after 7 days. Blue: nuclei
(DAPI); Red: actin (rhodamine phalloidin); Scale bar: 200 µm
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Figure 4.4: Representative stress-strain curves of low, medium, and high stiffness hydrogels with or without
benzophenone.
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Figure 4.5: Increased substrate stiffness induces osteogenic differentiation. (A) Osteogenic (ALP, COL1A1,
OCN) and adipogenic (PPARG) gene expression of cells cultured on varying stiffness substrates without
BMP-2 normalized relative to the softest substrate. Data are mean ± SEM, n=3, (*) significantly different
than other two experimental groups, p ≤ 0.05; (∨) significant linear trend with decreasing stiffness, p ≤ 0.05.
(B) ALP activity, expressed as glycine units (U), of cells cultured on substrates of varying stiffness without
BMP-2 after 7 days. Data are mean ± SD, n=3, (*) significantly different than other two experimental
groups at the same time point, p ≤ 0.05.
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Figure 4.6: Combined effects of immobilized BMP-2 and stiffness on osteogenic differentiation. (A) Relative
osteogenic (ALP, COL1A1, OCN) and adipogenic (PPARG) gene expression after 7 days as a function of
stiffness compared to soft substrate without BMP-2. Data are mean ± SEM, n=3, (*) significantly different
than other two experimental groups, p ≤ 0.05. (B) ALP activity, expressed as glycine units (U), of cells
cultured on varying stiffness substrates containing immobilized BMP-2 after 7 days. (C) Relative ALP
activity on day 7 of cells cultured on varying stiffness substrates containing immobilized BMP-2 normalized
relative to the substrate without BMP-2. Data are mean ± SD, n=3, (**) significantly different than other
two experimental groups, p ≤ 0.01.
78
Figure 4.7: Representative optical micrographs of cell-seeded hydrogels stained with Oil Red O after 7 days.
Lipid droplets, characteristic of adipogenic lineage, decrease with higher stiffness and BMP-2. Overlay of
fluorescent and transmitted light images. Red: Oil Red O; Blue: DAPI (nuclei); Black arrows indicate cells
negative for Oil Red O staining; Scale bars: 100 µm
Figure 4.8: Schematic of photoreactive hydrogel concept used to orthogonally tune mechanical and biomolec-
ular properties.
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4.7 Tables
Table 4.1: Gene-specific primer sequences.
Gene Forward primer sequence (5’→3’) Reverse primer sequence (5’→3’)
ALP CCCTTCACTGCCATCCTGTAC GGTAGTTGTCGTGCGCATAGTC
COL1A1 AGAAGAAGACATCCCACCAGTCA CCGTTGTCGCAGACACAGAT
OCN GAGGGAGGTGTGTGAGCTCAA GGCTGCGAGGTCTAGGCTATG
PPARG GAGCCCAAGTTCGAGTTTGC GGCGGTCTCCACTGAGAATAAT
GAPDH GTCAAGCTCATTTCCTCGTACGA CTCTTACTCCTTGGAGGCCA
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Chapter 5
Conclusions
The work described in this dissertation set out to develop enabling tools for guiding cell-substrate interac-
tions in a systematic and controllable manner. Despite significant research investment and activity, clinical
advances in cell-instructive materials and the field of tissue engineering in general have not kept pace with
expectations. Although it is widely recognized that cellular function is determined by a constellation of
cues, much of the scientific literature still focuses on the role of a single factor or class of signals. In or-
der to gain and apply insight from the native cell microenvironment, biomaterials of increasing complexity
and spatial heterogeneity are required. A simple, universal strategy that allows presentation of a wide
range of biomolecules along with tunable mechanical properties has significant potential to recapitulate key
characteristics of the ECM.
The benzophenone photolithography method overcomes important limitations in the design of bioma-
terials. The promise of this approach was demonstrated in Chapter 2, in which neutrophil flow assays on
P- and E-selectin substrates shed light on the anti-inflammatory effect of bromelain. Chapter 3 illustrated
the importance of mimicking functional characteristics of tissue to investigate stem cell differentiation in the
context of multiple chemical cues and variable mechanical properties on collagen-glycosaminoglycan mem-
branes. In Chapter 4, I extended the utilization of benzophenone to softer substrates using hydrogels to
examine the interrelationship of mechanical and biochemical signaling on osteogenesis.
Taken together, the work presented here highlights the utility of this method; however, much remains to
be understood about the complex microenvironment. There is a need to better understand the answers to
fundamental biological questions, such as:
• How do cells integrate competing or synergistic signals?
• Do spatial variations (i.e. gradients) and organized heterogeneity in signaling matter?
• Is there a critical threshold for mechanical or biochemical cues?
• How do cell characteristics in three-dimensional environments differ from those cultured in two dimen-
sions?
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• Are cell fate and function decisions reversible?
Overall, these studies have contributed to a more quantitative understanding of how cells process the co-
operative effects of multiple factors. Researchers must continue to systematically investigate multiparametric
cell behavior in order to develop and fully realize therapies that imitate nature.
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Appendix A
A Photocleavable Linker for
User-Mediated Release of Growth
Factors
A.1 Introduction
The work described thus far has demonstrated control of cell-material interactions through immobilization
of multiple biomolecules as well as tissue-matched mechanical properties. Future directions in creating cell
instructive materials must extend to controlling biomolecule activity in time and space to fully recapitulate
the complex ECM .
Towards the creation of dynamically responsive materials, we sought to make a tri-functional linker that
can be coupled to the biomaterial surface (e.g. CG scaffold), conjugate the desired growth factor (e.g.
protein or peptide), and release the growth factor at the desired time. Using a photolithographic strategy
for selectively cleaving chemical cues provides the same advantages as demonstrated in the body of this
dissertation: facile control of the location and amount of photocleavage via modulation of light exposure.
Thus this strategy would allow the researcher to turn “off” the signal at a later time point or spatial location
by removing the bioactive molecule. Alternatively, release of the molecule could allow its subsequent delivery.
The complete linker and UV-mediated nitrobenzyl cleavage is shown in Figure A.1A. The heterofunctional
linker consists of hydrazinonicotinamide (HyNic) and sulfhydryl moieties for conjugation on either end.
A.2 Materials and methods
A.2.1 Solid phase synthesis of tri-functional linker
The photocleavable linker was constructed using solid phase peptide synthesis on 0.1mmol scale starting
with Fmoc-Cys(Trt) Wang resin. Resin (Chem-Impex Inc, 0.55 mmol/g) was swollen in dimethylformamide
(DMF), deprotected using 20% piperidine in DMF, and coupled to Fmoc-Peg2-OH (Chem-Impex) using
1:1:2 ratio of amino acid/HCTU/N-Methylmorpholine. Three more coupling steps were carried out: Fmoc-
2-nitro-β-phenylalanine (Chem-Impex), then Fmoc-Peg2-OH, and finally Boc-HyNic (Solulink) were added
sequentially. Finally, the resin was washed with DMF, washed with ethanol, and cleavage from the solid
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support carried out in a separate flask. The resin was removed by filtration, TFA evaporated from the fil-
trate, and ice cold diethyl ether added to extract the peptide. The resulting viscous yellow oil was analyzed
by ESI-MS. Initially, the deprotection was performed using TFA/DTT/water/triisopropylsilane (88/5/5/2)
for 1.5 hours; however, this resulted in species 40 mass units less than expected due to Boc deprotec-
tion producing the free hydrazone on the N terminus (Figure A.1B). The cocktail TFA/acetone/water/TIS
(92.5/2.5/2.5/2.5) produced the acetone hydrazone with expected molecular weight (Figure A.1C). This
cocktail was tested with added DTT, which appeared to improve the observed yield of desired product
(Figure A.1D). Note: the presence of acetone is critical.
A.2.2 Linker conjugation to substrate and payload
Growth factors of interest can be readily modified through primary amines using NHS-maleimide, which
can be attached to one side of the linker through its cysteine moiety. Sulfhydryl groups occur in very low
abundance in type I collagen, so maleimides will not be conjugated nonspecifically to collagen substrates.
The other end of the linker, HyNic, can be covalently attached to an aryl aldehyde modified surface (e.g.
collagen scaffold treated with succinimidyl-4-formylbenzamide).
To prepare collagen membranes, the dry membranes were weighed, then soaked in ethanol for sev-
eral hours, then soaked in 100 mM phosphate buffered saline pH 7.4 overnight. The correct amount of
sulfo-S-4FB reagent (Solulink) was determined according to the manufacturer’s protein/peptide conjugation
calculator. Briefly, a 3-fold molar excess of Sulfo-S-4FB was reacted with the membranes by adding 21.2
µL of sulfo-s-4FB stock solution (5 mg/mL in DMF) to the membranes in 7 mL PBS (“concentration”=dry
membrane mass/final volume=2.5 mg/mL; collagen mw=175 kDa). The membranes were incubated at room
temperature for 2 hours, then rinsed three times with PBS and stored in PBS in the dark at 5 °C until use.
Next, the photocleavable linker was attached to collagen-4FB membranes (n=6) by incubating 174 µg
peptide linker for 2 hours in a solution of 100 mM PBS + 20mM aniline at pH 6.
As a first step to illustrate attachment and release using the linker peptide, we attached the fluorophore
fluorescein-maleimide (Fisher) to the end of the linker. Membranes were incubated with fluorescein-5-
maleimide (25-fold molar excess dye with respect to the total amount of linker added) overnight at 5 °C.
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A.3 Preliminary progress towards light-controlled growth factor
delivery
The substrate was exposed to UV light (λ=350-365 nm, power 50mW/cm2) for 4 minutes. Substrates
were rinsed in PBS, and the fluorescence of the supernatant and the collagen surface were measured to
determine released and immobilized fluorescein (Figure A.2). Preliminary results suggest that UV exposure
does cause dye to release from the membrane. Considerable fluorescein release was measured in control
substrates incubated with fluorescein-maleimide only (no peptide linker), suggesting that further rinsing
may be necessary to remove nonspecific attachment to the collagen membranes.
Overall, the photocleavable linker was successfully synthesized and shown to mediate the release of a
fluorescent dye from collagen membranes. This user-defined removal strategy could be a useful approach to
temporally control the release of growth factors in order to orchestrate changes in cell behavior via dynamic
biochemical signaling.
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A.4 Figures
Figure A.1: Synthesis of nitrobenzyl-containing photocleavable linker.
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Figure A.2: Characterization of fluorescein dye released from collagen membrane.
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